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ABSTRACT 
   
Title of dissertation:    The functional importance and significance of 
ecdysteroids in molt-cycle regulation of the blue crab, 
Callinectes sapidus 
 
 Sirinart Techa, Doctorate of Philosophy, 2014 
Dissertation directed by Associate Professor J. Sook Chung 
 Marine Estuarine Environmental Science 
 
 This study aims to expand our understanding of how ecdysteroids and 
neuropeptide hormones (MIH/CHH) regulate molting in crustaceans using the 
blue crab Callinectes sapidus as a model animal.  The hypothesis of this study is 
that ecdysteroids have a stimulatory effect on MIH/CHH production in eyestalks 
while generating both positive and negative feedback on ecdysteroidogenesis in 
Y-organs.  Since ecdysteroids exert their signals through an ecdysteroid receptor 
complex, composed of an ecdysone receptor (EcR) and its partner, the retinoid-X 
receptor (RXR), the functional activity of ecdysteroids on tissues of interest is 
examined through EcR expression.  Endogenous levels of ecdysteroids as well 
as expression in EcR, RXR and MIH/CHH are assayed in both embryonic and 
juvenile molt cycles.  Similar patterns of changes in these two cycles suggest that 
molting control is driven by the same mechanisms in each.  During embryonic 
molt, the correlation of ecdysteroid levels and MIH/CHH expression suggests that 
ecdysteroids are involved in MIH/CHH production.  Using an in vitro system, 
stimulation of MIH expression occurs in eyestalks incubated with ponasterone A 
(PoA) and 20-hydroxyecdysone (20-HE) in the ratio found endogenously (3:1) 
and in ecdysteroid concentrations of 75 and 150 ng/ml.   The in vivo response of 
MIH expression to depletion of ecdysteroid signals was examined by RNAi 
knockdown of an ecdysone receptor that was found to reduce the levels of MIH 
to those found by MIH knockdown, providing support for the hypothesis that 
ecdysteroids stimulate MIH expression through an ecdysone receptor.  This 
study also found evidence suggesting that crustaceans have long-loop feedback 
for ecdysteroids in the neuroendocrine axis, which is similar to that found in 
insects.   
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CHAPTER 1.  INTRODUCTION  
 
1.1  Molting and its regulation 
 Growth and the developmental processes of all animals involves an 
increase in body size and changes in body-plan formation.  However, these 
changes in arthropods are limited to their exoskeleton.  In order to grow, the old 
shell must be shed and the new one synthesized.  This process is called molting.  
Since molting is essential for growth and development in arthropods, the 
mechanisms that regulate these processes must be better understood.   
It has been well documented that molting is stimulated by ecdysteroids 
and the circulating levels of ecdysteroids in all arthropods highly correlate with 
the molt stages  [1-9].  As a comparison, the regulation of ecdysteroidogenesis in 
insects and crustaceans is different.  In insects, prothoracicotropic hormone 
(PTTH) is produced in the brain and secreted from the corpora allata to stimulate 
prothoracic glands that then produce ecdysteroids [10-12].  Alternatively, 
neuropeptides, produced in the eyestalks of crustaceans, suppress 
ecdysteroidogenesis in the Y-organs, which is equivalent to the prothoracic gland 
[5,13-23].  It has been reported that ecdysteroids have stimulatory effects on the 
production of PTTH in Manduca sexta [24-27].  Moreover, it has been proposed 
that ecdysteroids may have a positive effect on neuropeptide production in the 








1.1.1  Neuropeptide hormones 
 
Insects  
 In insects, PTTH is produced in the brain and secreted by the corpora 
allata to stimulate the prothoracic gland.  PTTH targets the prothroracic gland 
and triggers ecdysteroidogenesis through a signaling cascade involving Ca2+, 
cAMP and a MAP kinase [11,29].  In addition to physiological and environmental 
cues such as weight gain and photoperiod, PTTH is positively regulated by 
ecdysteroids as reported in M. sexta [24-27].  As reported in M. sexta and Pieris 
brassicae, ecdysteroids also generate a short-loop feedback on the prothoracic 
gland.  Lower levels stimulate, while higher titers inhibit the action of the 
prothoracic gland [30-32]. 
 
Crustaceans 
 The finding that the molting progression is induced by eyestalk ablation 
[33] has led to the discovery that molting in crustaceans is suppressed by 
eyestalk factors, which were later attributed to neuropeptides.  Neuropeptide 
hormones belong to the crustacean hyperglycemic hormone (CHH) family and 
include CHH, molt-inhibiting hormone (MIH), gonad-stimulating and -inhibiting 
hormone (GS/IH), and mandibular organ-inhibiting hormone (MOIH) [34-38].  
MIH and CHH are synthesized in neurosecretory cells in the X-organ located 
within the eyestalk ganglia.  These neuropeptides are transported through the 
axonal tract, stored in the sinus gland, and secreted into the hemolymph to 
suppress ecdysteroidogenesis in Y-organs [18-21,37,39-43].  Inhibitory actions of 
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MIH and CHH on the Y-organs have been reported in several crustaceans 
including Carcinus maenas, Callinectes sapidus, Gecarcinus lateralis, 
Procambarus clarkii, and Uca pugilator through in vitro incubation studies [5,13-
22,44,45].  In addition, only two in vivo studies confirm the intrinsic hormonal 
signaling of MIH and CHH on the activity of Y-organs [37,46].  
 To date, regulation in the levels of MIH expression during the molt cycle 
has not been well understood.  A few reports indicate that ecdysteroids may have 
an effect on the levels of MIH in the eyestalks.  Administering ecdysteroids in 
Cancer anternarius increased neuropeptide production in eyestalk ganglia [28].  
Moreover, there is a report in Uca pugilator that a concentration of ecdysteroids 
in the eyestalk ganglia was higher than the hemolymph [14], implicating a 
possible accumulation of ecdysteroids in this tissue.  Recent studies have shown 
that the upstream promoter regions of MIH genes, isolated from C. pagurus and 
Charybdis feriatus, contain the binding sites for ecdysteroid-responsive factors 
[45,47].  Furthermore, hemolymph titers of MIH and CHH during the molt cycle of 
C. maenas show that MIH levels are significantly higher during the late premolt 
compared to the other stages [48].  These lines of evidence suggest that 
ecdysteroids may have a positive effect on the expression of neuropeptides in 







1.1.2  Ecdysteroid hormones 
 Ecdysteroids are a class of steroid hormones that are derived from 
cholesterol and found in animals, plants and fungi [1,2].  Ecdysteroids play 
important roles in several processes in arthropods, most significantly in molting.  
Ecdysteroidogenesis in the prothroracic gland or Y-organ is similar, but the 
crustacean Y-organ produces a greater diversity of ecdysteroids [49-52].  
According to the review by Mykles [52], the synthetic pathway of ecdysteroids 
can be divided into two stages: 1) conversion of cholesterol to 5-diketol, and 2) 
conversion of 5-diketol to secreted products. The former stage is common to all 
decapod species, while the latter one has four pathways that are named 
according to the secreted ecdysteroids by the Y-organ: 1) ecdysone, 2) 3-
dehydroecdysone, 3) 25-deoxyecdysone, and 4) 3-dehydro-25-deoxyecdysone 
[52].  Among the four forms, crustacean ecdysteroids are usually secreted in 
three forms (ecdysone, 3-dehydroxyecdysone, 25-deoxyecdysone, and 3-
dehydro-25-deoxyecdysone) depending on the species [50,52-55].  In peripheral 
tissues, these compounds are modified to an active form.     
It is well known that molting is induced by ecdysteroids.  Molt stages are 
defined by the levels of hemolymphatic ecdysteroids and setogenesis [3-9,56].  
Within a molt cycle, ecdysteroid titers fluctuate: low during postmolt and 
intermolt, increasing at early premolt, peaking at midpremolt and returning to 
basal levels prior to ecdysis, as reported in C. magister, C. maenas, C. sapidus, 
Daphnia magna, Hyas araneu, Metopograpsus messor, and P. clarkii (Fig. 1-1) 
[3-9].   
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The clearance of ecdysteroids in crustaceans is reported in Homarus 
americanus, and the rate is molt-stage dependent: lowest at early premolt, 
followed by the mid premolt stage, and highest during the postmolt and intermolt 
stages [57].  Ecdysteroids were hydrolyzed into high polarity metabolites 
including 20-hydroxyecdysonoic acid and 20, 26-dihydroxyecdysone and were 
excreted in urine (95%), while the apolar metabolites were found in feces (5%) 
[58,59].  Therefore, it is suggested that titers of circulating ecdysteroids during 
each molt stage are determined by the difference between the rate of synthesis 




Figure 1-1.   Circulating ecdysteroid from a C. sapidus female during the last two molts: 
pre-pubertal molt and adult molt assayed by ecdysteroid-RIA. Numbers on the X-axis 
represents days before each molt.  C4= intermolt, D0= early molt, D1-D2= mid premolt, 











































Nuclear hormone receptor superfamily 
 Nuclear receptors are phylogenetically related proteins clustered into a 
large superfamily, including receptors for hydrophobic molecules such as steroid 
hormones, retinoic acids (all trans and 9-cis isoforms), thyroid hormones, and 
fatty acids [61].  Nuclear receptors are commonly found in sponges and 
Metazoans including echinoderms, tunicates, arthropods and vertebrate [62].   
 The nuclear hormone receptor family is characterized by 5-independent 
functional domains (domains A-F as originally defined by Krust): 1) A/B or N-
terminal domains or activation function-1 (AF1): exhibiting ligand-independent 
trans-activation;  2) C or DNA-binding domain (DBD): binding to regulatory 
elements of the target genes; 3) D or hinge region (HR) domain: providing 
flexibility within the molecule; 4) E or ligand-binding domain (LBD): serving as 
docking sites for its cognate ligands and transcriptional regulators (co-activator or 
co-repressor); and 5) F or C-terminal or AF2 domain: trans-activating with ligand-
dependent manner [63-65] as shown in Fig. 1-2.  
 Since the DBD and AF reside within the same molecule, the nuclear 
hormone receptor can directly trans-activate the target genes when its cognate 
ligands bind to the LBD [66].  In general, binding of the ligands to the LBD 
stimulates conformational changes in the LBD and AF2 which strengthens 
partner dimerization or releases a co-repressor.  Eventually, the pre-initiation 





Figure 1-2.   Schematic illustration of the structural and functional organization of a 
nuclear hormone receptor family.  The evolutionarily conserved regions C and E are 
indicated as white and grey boxes, respectively, while the line represents the divergent 
regions A/B, D, and F. Two transcription activation functions (AFs) have been described: 
a constitutively active AF1 in the A/B region and a ligand-inducible AF2 in region E or F. 
DBD: DNA binding domain, LBD: ligand binding domain, and NLS: nuclear localization 
signal [67].  
 
Ecdysteroid-responsive genes 
 After receiving the ecdysteroid signals, the EcR-RXR complex, a master 
transcription factor, will trigger the expression of downstream transcription factors 
including EcR-RXR itself.  In Drosophila, the EcR/USP heterodimer induces the 
expression of early ecdysteroid-responsive genes such as Broad complex, E74, 
and E75 which are required during development and metamorphosis [68-75].  
The Broad complex gene is located in the 2B5 locus and encodes three alternate 
pairs of C2H2 zinc finger motifs for binding to regulatory elements of late 
ecdysteroid-responsive genes such as E71 [70,72,76].  E74 genes encode an 
ETS DNA-binding domain [73,77-80], while E75 genes located in 75B locus 
encode a nuclear hormone receptor [72,81-83].  Although these transcriptional 
factors are downstream of ecdysteroid responses, their transcription is directly 














Figure 1-3 . Schematic diagram illustrating the differential effects of ecdysteroids titers 
on the expressions of their responsive genes in Drosophila: higher levels of ecdysteroids 
trigger early ecdysteroid- responsive genes including of the Broad complex (BR-C), 
E74A, E75A and EcR.  2Bc and br are alleles of Broad complex genes [73]. 
 
1.2.  The blue crab, Callinectes sapidus 
  
 Blue crabs, Callinectes sapidus, are classified into the Phylum Arthropoda 
and Subphylum Crustacea.  C. sapidus belongs to the family known as 
Portunidae and is distributed across two hemispheres from the north Atlantic 
coast of the United States to the coast of Uruguay in South America [84].  Blue 
crabs are important to the ecosystem and commercial fishery along the 
Chesapeake Bay where the brood stock density has drastically declined in the 
last few decades.  Therefore, a better understanding of how their growth is 
regulated is necessary.   
 Similar to other arthropods, blue crabs undergo growth, development, and 
reproduction through molting.  Molting in C. sapidus is repeated 27 to 29 times 
during their lifecycle starting from hatching and until adulthood (Fig.1-4) [60].  As 
a result, the body size increases 20-50% in each molt cycle, which is referred to 
as a molt increment.  Females undergo a terminal-pubertal molt during the active 





Figure 1-4.   Lifecycle of C. sapidus starting from (1) a sponge female carrying the 
fertilized eggs, (2) developing embryo inside embryonic envelopes, (3) hatching larva, 
(4) megalops, (5) juvenile and (6) adult crab.   
 
1.2.1.  Ovarian development 
 Similar to other arthropods, reproduction in the adult female crab includes 
nuclear replication, oocyte differentiation, and yolk (or vitellin) deposition [86].  
The early phase of oocyte development, called previtellogenesis, occurs during 
both sexual rest and reproductive activity.  During this phase, the cellular 
organelles are synthesized and the glycoproteins are accumulated [87].   
The latter phase is vitellogenesis and only occurs during reproduction.   
Vitellogenesis is involved in the synthesis of vitellogenin, a precursor yolk protein, 
in the fat body of insects or hepatopancreas of crustaceans [23,88,89].  After 








the hemolymph and endocytosed into the oocytes [87].  The differentiated 
oocytes continue accumulation of vitellin, maternal mRNAs, and other 
cytoplasmic proteins, resulting in a significant increase in oocyte diameter 
[23,87,90].  Moreover, vitellin is known as a carrier of the ecdysteroids that are 
required for early embryogenesis in insects and crustaceans [91-96]. 
 
1.2.2  Embryonic development 
In C. sapidus, the fertilized eggs are extruded from the gonopores of the 
females and attached on the inner-branch hairs (ovigerous hairs) of swimmerets, 
and this egg mass is referred to as sponge [97].  The developmental stages of 
decapod embryos such as C. maenas, C. sapidus, H. americanus and Palaemon 
serratus are classified according to the size of remaining yolk, together with the 
levels of development of eyes, appendages, and heart [98-101]. 
 In C. sapidus, embryogenesis is divided into five stages based on the 
criteria reported in C. maenas, as shown in Fig. 1-5 [98].  The yolk stage includes 
embryos from zygotic formation until the end of gastrulation.  Organogenesis 
occurs at the limb-formation stage when the divided cells are differentiated and 
migrate to one pole of the egg, forming a clear cluster of these cells.  The 
organogenesis of the embryos continues and can be observed by the presence 
of eye pigment at the eye-anlage stage.  While the eyes continue to develop, the 
heart starts to function at the heart-beat stage.  Eye development is completed at 
the developing-eye stage and the fully-developed embryos are referred to as 
hatching imminent.  In C. sapidus, these processes are completed in 14-19 days 
 
depending on water temperature 
zoeae (Zoeal stage 1). 
 
Figure 1-5.   The developmental stages of 




which results in the release of ecdysteroids
the levels of ecdysteroids during
suggest that zygotic ecdysteroidogenesis
[102] and the larvae are released as the first 
C. sapidus embryos classified according to 
 
embryogenesis, vitellin is being continuously utilized 
 [101,103,104].  However, changes in 
 embryogenesis of decapod crustaceans 
 may occur during this period
11 
  
 [100,105].   
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1.2.3.  Larval and post-larval development  
 After hatching, the released larva are called zoea and have a cylindrical 
shape, a long and sharp beak, two pairs of antennae, and four pairs of leg-like 
appendages [97,106].  The zoea undergoes 7 or 8 cycles of molting and finally 
becomes a post-larval form called a megalopa.  The megalopa has a flattened 
body with a shorter and wider abdomen than that of the zoea.  In C. sapidus, the 
megalopa metamorphoses into the first juvenile crab (crab 1) [97].  
 Development of zoeae and megalopae in the Chesapeake Bay might be 
affected by endocrine disruptors, a consideration due to the transport of larvae 
and megalopae to lower salinity in the upper bay.  During this period, the bay 
watersheds peak in contamination with pesticides that are considered endocrine 
disruptors, such as atrazine, chlordane and endosulfan [107-111].  In particular, 
endosulfan sulphate promotes embryonic abnormalities, reduces molting 
frequency, and interferes with molting processes through blocking of the binding 
of ecdysteroids and EcR as reported in D. magna and Macrobrachium 
malcolmsoii [110-112].  Therefore, it is possible that the blue crab population 
might be affected by these endocrine disruptors that interfere with molting.   
 
1.2.4.  Molt stages and physiological changes 
 During the molt cycle, physiological and structural changes are closely 
related to molt stages, and crustacean molting is classified into four different 
stages: intermolt (C4), premolt (D0-4), ecdysis (E), and postmolt (A-C3).  Premolt is 
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further characterized by three stages: early premolt (D0), mid premolt (D1-D2), 




Figure 1-6 .  A schematic diagram of the molt cycle of C. sapidus with associated 
phenotypic changes of the swimming leg.  Inner ring: blue=premolt, yellow=ecdysis, and 
light blue=postmolt; outer ring: color represents the progression of molting: 
blue=intermolt (C4), magenta=premolt (D0-D4), red=ecdysis (E), purple=postmolt (A-B). 
(http://www.serc.si.edu/education/resources/bluecrab/molting.aspx) 
 
Normal activities such as eating and swimming occur during intermolt 
when the exoskeleton is rigid, and the membranous tissue is attached to the 
hypodermis and the cuticle [115].  During premolt, the old cuticle is detached 
from the hypodermis by digestive enzymes (chitinases) secreted by epithelial 
cells [116], while the new cuticles composed of an organic matrix are laid.  At the 
late midpremolt (D2) stage, organic materials from the old shell are reabsorbed, 
resulting in a breakable shell.  Ecdysis begins through the breakage of the 
ecdyseal line assisted by the hydrostatic pressure that is generated by the water 
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uptake induced by the release of gut-borne CHH [117,118].  After tanning and 
calicification during postmolt (A, B, C1-C3 stages), the animals resume normal 
activities.  
  
1.2.5  Ecdysteroids during a molt cycle  
In C. sapidus, a recent study reported that during the mid premolt (D2) 
stage, Ponasterone A (PoA) is the major active form followed by 20-
hydroxyecdysone (20-HE) as shown in Fig. 1-7, and they are circulated with a 
3:1 ratio [60].  Interestingly, ratios of the two major forms in the last three molts 
seem variable when the ratios of 20-HE to PoA are increased when the animals 
become mature.   
 
 
Figure 1-7.  Different forms of ecdysteroids circulating during mid premolt (D2) from 
juvenile (black bar), pre-pubertal (light-grey bar), and adult (grey bar) molts, assayed by 
HPLC-RIA.  % Ecdysteroid represents percentages of 20-hydroxyecdysone (20-OH E), 
ecdysone (E), 3-dehydroxyecdysone (3 dehydro E), Ponasterone A (PoA), 25-







1.2.6  Ecdysteroid receptor complex in C. sapidus (CasEcR and 
CasRXR) 
 
In a previous study, cDNA sequences encoding for EcR and RXR in C. 
sapidus (CasEcR-CasRXR) were isolated and characterized [119].  The  5’ 
untranslated region (5’UTR) of both the CasEcR and CasRXR cDNA sequences 
contain translational regulatory sites: an upstream open reading frame (uORF) 
and an internal ribosome entry site (IRES).   
Messenger RNAs containing uORFs are often up-regulated in their 
translations under stress or a starvation condition, while the translations of other 
mRNAs are down-regulated by phosphorylated Eukaryotic Initiation Factor 
2 (eIF2) [120].  Reduction in the levels of ternary complexes (Met-tRNAi
Met and 
eIF2-GTP) will slow the reinitiation of uORFs and allow the 40S preinitiation 
complex to scan through the encoding ORF.  On the contrary, IRES provides an 
alternative pathway for translation initiation.  Specific mRNAs containing IRES 
can be continuously translated when the cap-dependent mechanism is impaired 
[121-123]. 
Four putative isoforms of both CasEcR and CasRXR are found in this 
species.  CasEcR is especially important because it binds directly to ecdysteroids 
[124,125].  Two putative CasEcR isoforms (CasEcR1a/CasEcR2a) have an 
insert in the HR domain that lies between the LBD and the DBD.  This insert 
(HRi) contains four residues of Pro that may generate steric hindrance and 
interfere with conformational changes, resulting in an inefficiency inof ecdysteroid 
transduction.  In addition, there are two types of ligand-binding pocket (LBP): 
type-1 (CasEcR1/CasEcR1a) and type-2 (CasEcR2/CasEcR2a) that differ in 
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hydrophobic fields (Fig. 1-8), suggesting that these differences may be 
responsible for binding with several forms of circulating ecdysteroids (Fig. 1-7).  
This notion seems to agree with the finding that during the mid premolt, two 
active ecdysteriods, PoA and 20-HE, are found in the hemolymph.  PoA is more 
hydrophobic than the 20-HE [60].   
Considered together, this suggests that type-1 CasEcR would be stronger 
for binding with 20-HE than PoA, whereas type-2 CasEcR would prefer to bind 
with the PoA.  However, the specific binding to ecdysteroids and significant roles 
of four CasEcR isoforms in molt-related tissues (eyestalks and Y-organs) still 
remain unknown.  CasRXR appears to have variations from inserted fragment(s) 
at the T-box within the DBD and/or at the anterior of the LBD.  Both inserts are 
predicted to have effects on the dimerization of CasRXR to its CasEcR partner 








Figure 1-8.   Isoform characterization of CasEcR (A) and CasRXR (B) from multiple 
alignment of putative encoding protein. Putative protein structures of CasEcR1 (A´) and 
CasEcR2 (A´´) analyzed with PyMol program based on the X-ray structure of Heliothis 
virescens EcR-USP complex bound to Ponasterone A.  Variations in CasEcR1 and 
CasEcR2 are labeled in the ball-and-stick model: green and red representing 
hydrophobic and hydrophilic residues, respectively.  Small legends represent surface 





















































1.3.  Hypothesis 
This study aims to expand the knowledge of how ecdysteroids and 
neuropeptide hormones regulate molting in crustaceans, using blue crab C. 
sapidus as a model animal.  The hypothesis of this study is that ecdysteroids 
have a stimulatory effect on neuropeptide production in eyestalks while 
generating both positive and negative feedback on ecdysteroidogenesis in Y-
organs.  Since ecdysteroids exert their signals through the ecdysteroid receptor 
complex composed of EcR and RXR, the functional activity of ecdysteroids on 
tissues of interest can be examined through EcR expression.  Two main 
objectives that guided the effort to determine whether ecdysteroids have a direct 
effect on activities of eyestalk ganglia included: 
1) An aim to determine the expression levels of endogenous 
neuropeptides (CHH and MIH), ecdysteroid-responsive factors (EcR, RXR, and 
BTBDP) and ecdysteroid levels during C. sapidus embryogenesis.  As proposed 
in research on arthropods, the first cycle of molting occurs during embryogenesis 
(referred to as embryonic molt).  Due to the times and patterns of their 
expressions, it has been suggested that there is an interaction between 
ecdysteroids and neuropeptides.  By obtaining these results, expressions of 
neuropeptides and ecdysteroids can be compared to determine whether the 
embryonic ecdysteroids are correlated with the newly produced neuropeptides. 
2) An aim to assess the direct effects of ecdysteroids on MIH expression 
in eyestalk ganglia where neuropeptides are specifically produced.  Endogenous 
expressions of MIH and EcR1, the major isoform in eyestalks, were examined 
19 
 
from eyestalk ganglia during the preceding juvenile molt.  In addition, expression 
of three isoforms of EcR in Y-organs was compared to determine whether the 
expression patterns were similar with those of the eyestalks.  Induction of 
ecdysteroids on MIH expression was performed by in vitro incubation of the 
intermolt eyestalks with different ecdysteroid concentrations and ratios that mimic 
endogenous ecdysteroids during the C. sapidus premolt.  To confirm direct 
interactions between ecdysteroids and MIH expression, knockdown of EcR1 
using double-stranded RNA (dsRNA) was carried out to test its functional 
significance in vivo.  It was expected that the dsRNA specific for EcR1 and MIH 




2.  CHAPTER 2   
 
Changes in ecdysteroid levels and expression patter ns of ecdysteroids-
responsive factors and neuropeptide hormones during  the embryogenesis 
of the blue crab, Callinectes sapidus 
 
Abstract 
 Embryogenesis requires the involvement and coordination of multiple 
networks of various genes, according to a timeline governing development.  
Crustacean embryogenesis usually includes the first molt, a process that is 
known to be positively controlled by ecdysteroids.  We determined the amounts 
of ecdysteroids, as well as other related factors: the ecdysone receptor 
(CasEcR), the retinoid X receptor (CasRXR), the molt-inhibiting hormone 
(CasMIH), and crustacean hyperglycemic hormone (CasCHH) during the ovarian 
and embryonic developments of Callinectes sapidus.  In summary, the ovaries at 
stages 1-4 have expression levels of maternal CasEcR and CasRXR 10-50 times 
higher than levels seen in embryos at the yolk stage.  This large difference in the 
amount of these factors in C. sapidus ovaries suggests that these maternal 
ecdysteroid-responsive factors may be utilized at the initiation of embryogenesis.  
During embryogenesis, the changes in total ecdysteroids and levels of CasEcR 
and CasRXR expression are similar to those observed in juvenile molts.  The full-
length cDNA sequence of the C. sapidus BTB domain protein (CasBTBDP) 
initially isolated from Y-organ cDNA, contains only Broad-Complex, Tramtrack, 
and Bric a brac (BTB) domains.  The levels of CasBTBDP are kept constant 
throughout embryogenesis.  The expression profiles of CasMIH and CasCHH are 
similar to the titers of ecdysteroids.  However, the timing of their appearance is 
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followed by increases in CasEcRs and CasRXRs, implying that the expressions 
of these neuropeptides may be influenced by ecdysteroids.  Moreover, the 
ecdysteroid profile during embryogenesis may track directly with the timing of 
organogenesis of Y-organs and their activity.  Our work reports, for first time, the 
observed expression and changes of ecdysteroid-responsive factors, along with 
CasCHH and CasMIH, during embryogenesis in the crustacean C. sapidus.    
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2.1  Introduction 
Embryogenesis is a developmental process that entails a complex 
network of regulatory genes [129].  The embryo of many arthropod species starts 
with a large amount of yolk protein (vitellins= VT) at fertilization.  Extensive 
research reports that for crustaceans, their embryos undergo molting within an 
embryonic envelope during a relatively long period of embryogenesis [95,99,130-
134].   
Molting is essential for growth and development that recapitulates 
throughout the life cycle of each given arthropod species.  During embryogenesis 
of decapod crustaceans, such as Carcinus maenas, Callinectes sapidus, 
Homarus americanus, and Palaemon serratus, the first molt occurs within 
embryonic envelopes [98-101].  Hatching coincides with the true first molt 
accompanied by shedding of the exuvium.  The crustacean molt is known to be 
regulated mainly through the interplay between ecdysteroids and neuropeptide 
hormones [34,35,37,38,98,135-137]  However, molecular mechanism(s) of the 
endocrine system by which the growth of embryos occur, still remains less well 
understood.   
The hormonal mechanism of hatching that accompanies shedding of the 
exuvium is equivalent to that of the ecdysis recapitulating events in juvenile and 
adult stages.  Both of these processes are likely driven largely by hormonal 
cascades and characterized by ecdysial behavior and a significant amount of 
water uptake [98,118].  During embryogenesis, eyestalk-originated 
neuropeptides, including crustacean hyperglycemic hormone (CHH) and molt-
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inhibiting hormone (MIH), are expressed early at the eye-anlage stage, with 
levels of these hormones continuing to increase until completion of 
embryogenesis [98].   
Ecdysteroids conjugated to VT and transported into oocytes play a critical 
role in the early embryogenesis of arthropods [91-96].  During embryogenesis, 
the utilization of VT often coincides with the release of ecdysteroids.  Therefore, 
embryogenesis is staged with the size of the remaining yolk, together with the 
development of eye, appendage, and heart tissues [98-101].  The continuous 
utilization of VT during crustacean embryogenesis may reflect the companion 
levels of ecdysteroids [101,103,104].  However, changes in the levels of 
ecdysteroids during embryogenesis of decapod crustaceans [100,105] suggest 
that the newly formed Y-organs are active for the production of zygotic 
ecdysteroids during this period.  
The functional importance of ecdysteroids involves the presence of 
ecdysteroids receptors (EcRs) and other ecdysteroid-responsive transcriptional 
proteins such as Broad complex (BR-C) and Broad-Complex-Tramtrack-Bric-a 
brac (BTB) domain protein (BTBDP) [70,138].  In C. sapidus, the presence of 
four different cDNAs of EcRs and RXRs suggests that there may be putative 
structural isoforms of these receptors [119].  BR-C, an early ecdysteroid-
responsive factor, is involved in reproduction, embryogenesis, and molting of  
both insects and crustaceans such as Drosophila melanogaster, Tribolium 
castaneum, and Penaeus monodon [139-144].  The functional role of BTBDP has 
not yet been examined during the embryogenesis of any crustaceans.  
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We aim to profile changes in eyestalk neurohormones and ecdysteroids 
during embryogenesis.  Herein, we report for the first time in crustaceans that 
expression levels of ecdysteroid-responsive factors (including CasEcR, CasRXR, 
and CasBTBDP) and CasMIH and CasCHH during the embryogenesis of the 
blue crab C. sapidus, correspond to the ecdysteroid profiles.   
 
2.2  Materials and methods 
2.2.1 Animal and sample collection 
 Study batches of adult females (C. sapidus) were obtained from a 
Chesapeake Bay watershed spawning ground by the annual winter dredge 
survey of the Virginia Institute of Marine Science (VIMS, Virginia) and screened 
for diseases [145,146].  Disease-free animals were maintained in a closed-
recirculatory system holding at 30 ppt artificial seawater at 22°-23°C (8L:16D), 
fed daily with chopped squid and shrimp, and monitored daily for the extrusion of 
eggs (= spawning).  Ovarian samples were collected from adult females and 
staged according to the criteria as described [147].  Upon spawning, embryos 
were biopsied at every two days until they hatched.  These embryos were 
examined for developmental stages under a dissecting microscope following the 













 Degenerate primers of CasBTBDP (Table 2-1) were generated based on 
conserved regions identified from the multiple sequence alignment 
(www.genome.jp/ClustalW) of the putative BR-C isolated in insects including A. 
aegypti (AY499537.1, AY499538.1, AY499539.1, AY499540.1), B. mori 
(NM_001111334.1, NM_001111333.1, NM_001043511.), and D. melanogaster 
(NM_001144672.3, NM_166897.2).  The identified conserved amino acid (aa) 
sequences were reverse translated 
(http://www.bioinformatics.org/sms2/rev_trans.html) using C. sapidus codon 
usage (http://www.kazusa.or.jp/codon/).  
 
2.2.3  PCR with degenerate primers of CasBTBDP with 5´and 3´ rapid 
amplification of cDNA ends (RACE)  
 
 The cDNAs for 5´and 3´ rapid amplification of cDNA ends (RACE) were 
generated with total RNA extracted from Y-organs of a juvenile female at 
intermolt stage as described [119].  The initial BTBDP sequence was obtained 
from a two-step PCR assay with degenerate primers [119,148-153].  Touch-down 
(TD) PCR was carried out with 3´RACE cDNA of Y-organ and primers of BTBDP-
dF1 and universal primers (UPM) using Advantage Taq Polymerase (BD 
Biosciences) under the PCR conditions as described [119,150-153].  A nested 
PCR was performed as described [119] with two primers: BTBDP-dF2 and 





Table 2-1  The list of primers for CasBTBDP cloning and expression analysis  
 
Forward                        5´ to 3´ Reverse 5´ to 3´  
dF1 ATHACNWSYGCYTTYGARAA dR1 TGRTGNACRTTVACYTCDCC 
dF2 TTYGTNGAYGTSACYYTSGCYTG dR2 ACYTCNCCRTGRTARATRAA 
F2 CACTCAAGTGGAACAATCACAAGTCC R1 CATCCTTCATGAAGACAATGGGGTG 
F3  GTCGCCTCATCACGAACCCAACAGCC R2 or qR GTAGTCGCTGCATGTTGACAGCACG 
qF CAGGAGGTATTCATTGACGTCACAC   
 
“d” represents degenerate primers.  'q' primers are for qRT-PCR assays. Forward 
primers (F1, F2, and F3) were used for 3' RACE and reverse for CasBTBDP (R1, and 
R2) were used for 5´RACE.   
 
 
 A band was identified with the expected size of 700 bp on a 1.5% agarose 
gel.  The remaining procedures for cloning, sequencing, and sequence analysis 
were described [149-153].  This initial sequence was used for generating the 
gene-specific primers (BTBDP-5R1, -5R2, -3F2 and -3F3 listed in Table 2-1) that 
were used for obtaining the full-length CasBTBDP using 5´ and 3´RACE, 
respectively.   
 
2.2.4  Sequence analyses of CasBTBDP 
The open reading frame (ORF) of the full-length cDNA sequence of 
CasBTBDP was identified with ORF Finder 
(http://www.ncbi.nlm.nih.gov/projects/gorf/).  The Conserved Domain database 
(http://www.ncbi.nlm.nih.gov/Structure/cdd) remarked the conserved domains.  
The sequence similarity of the deduced aa sequences between CasBTBDP and 
other arthropod BR-C was analyzed using ClustalW (http://www.ebi.ac.uk) and 
Boxshade server (http://www.ch.embnet.org/software/BOX_form.html).  The 5´ 
and 3´ UTR sequences of CasBTBDP were further analyzed to examine whether 
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or not they contained putative translational regulatory elements using RegRNA 
(http://regrna.mbc.nctu.edu.tw/html/prediction.html) [154].   
 




 Staged ovaries and embryos (~30 mg) were homogenized in ice-cold 
DEPC-treated PBS and dissolved in 0.1 M borate buffer (pH 8.0).  Our 
preliminary data showed that the same amounts of total ecdysteroids were 
measured in both the crude extract and the samples treated with esterase and 
protease (unpublished results).  Therefore, the samples homogenized in the 
borate buffer were estimated for the levels of ecdysteroids using the same 
protocol as described [60].  The amounts of ecdysteroids were calculated using 
AssayZap program (BIOSOFT) and presented in pg/oocyte or pg/embryo. 
 
2.2.6  Expression levels of ecdysteroid-responsive factors ( CasEcRs, 
CasRXRs, and CasBTBDP) and neuropeptide hormones ( CasMIH and 
CasCHH) using qRT-PCR assays 
 
 
 Embryos at various developmental stages (10-20 mg wet weight/ sample) 
were homogenized in 150 µl of ice-cold DEPC-treated PBS.  Two thirds of each 
of these homogenized samples was used for the total RNA by following the 
procedures described [153].  After treating with DNase I (Fermentas), the total 
RNAs (1.5 µg) were subjected to cDNA synthesis using RevertAid Reverse 
Transcriptase (Fermentas) and finally diluted to 12.5 ng total RNA/µl.  The 
sample cDNAs (25 ng of total RNA eqv.) of ovaries, embryos, and zoeae were 
28 
 
estimated in duplicate for levels of CasBTBDP, CasMIH, and CasCHH 
expression, using Fast SYBR Green Master Mix (Applied Biosystems) on an 
Applied Biosystems 7500 instrument.  In particular in this study, the expression of 
CasCHH only in the eyestalk, not in the pericardial organ was measured [153].  
For measuring total levels of CasEcRs and CasRXRs, the primers were designed 
from the region that was conserved and shared in all four isoforms.  Arginine 
kinase (AK) was measured in the same sample cDNAs as a reference gene.  
The standards for qRT-PCR assays were generated similarly as described 
[149,150,152,153].  The expression levels are noted as copies/µg total RNA. 
 
2.2.7  Immunolocalization of CasMIH and CasCHH in C. sapidus embryos 
 Whole-mount immunohistochemistry was carried out for the localization of 
CasCHH and CasMIH in the embryos at heart-beat and developing-eye stages 
by following the procedures as described [98].  Embryos were fixed in a 
Drosophila fixative overnight [150] and their embryonic envelopes were removed 
for antisera penetration.  After washing with PTX containing 0.05% sodium azide, 
the embryos were incubated with specific anti-rabbit-CasMIH serum [23] or -
CasCHH serum that recognized CHH present only in the eyestalk ganglia [149] 
at a final dilution of 1:2,000 for 3 days at room temperature.  After washing as 
above, the embryos were incubated with an Alexa 488 conjugated goat anti-
rabbit IgG (Life Technologies) as described [150].  The embryo samples that 
were obtained from at least 3-4 adult females were examined using a confocal 
microscope (Zeiss), with the pictures collected using Z projection (BioRad).  The 
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staining intensity and area of CasCHH and CasMIH were determined and 
compared using ImageJ (http://imagej.nih.gov/ij).  
 
2.2.8  Statistical analysis  
 All results represent mean ± 1SE (n), in which n is the number of 
replicates.  The data were subjected to the normality test using the Shapiro-Wilk 
test (SigmaPlot) prior to all statistical tests SigmaPlot (version 12.3).  The data 
that did not show a normal distribution were analyzed using nonparametric 
ANOVA (Kruskal-Wallis Test) or unpaired t test.  In all cases, statistical 
significance was accepted at P<0.05 and noted with letters or asterisks (* or **) . 
 
2.3. Results 
2.3.1  Changes in the levels of ecdysteroids during  ovarian and embryonic 
development 
 
 Significant changes in amounts of total ecdysteroids are observed during 
ovarian development and embryogenesis (Fig. 2-1).  The stage-1 ovary shows 
undetectable amounts of total ecdysteroids, while the stage-2 ovary contains 0.3 
± 0.1 pg/oocyte (n=7), the similar amount as observed in the stage-3 ovary.  The 
levels of ecdysteroids are positively co-related with ovarian development and 
significantly (P<0.001) increased from 0.3 ± 0.1 pg/oocyte (n=5) at stage 3 to 0.9 








Figure 2-1.   Levels of ecdysteroids by Ecd-RIA during ovarian (inset) and embryonic 
development  The data are presented as mean ± SE pg/oocyte or embryo.  All data were 
subjected to a normal distribution using the Shapiro-Wilk test (SigmaPlot).  When the 
data did not show the normal distribution, a nonparametric test (Mann-Whitney Rank 
Sum test) was employed.  Statistical significance was accepted at P < 0.05 and noted 
with letters at each developmental stage.  n.d.= not detectable in  
 
 At the yolk stage, the ecdysteroid levels observed are statistically 
significant (P<0.001) reduced to 0.3 ± 0.1 pg/embryo (n=6) from 0.9 ± 0.1 
pg/oocyte at ovarian stage 4.  At the limb-formation stage, the ecdysteroid levels 
start to rise (1.0 ± 0.4 pg/embryo, n=12) and continue to increase significantly 
(P<0.001) to 7.9 ± 0.1 pg/embryo (n=9) at the eye-anlage stage and 11.1 ± 1.5 
pg/embryo (n=6) at the heart-beat stage.  Total ecdysteroid levels reach a peak 
at the developing-eye stage (21.3 ± 4.4 pg/embryo, n=9).  With hatching-
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imminent embryos, these levels then precipitously drop to 7.8 ± 1.5 pg/embryo 
(n=7), similar to the levels observed at the eye-anlage and heart-beat stages, 
and continue to decrease significantly (P<0.05) to 2.3 ± 0.5 pg/embryo (n=5) at 
zoeal stage (Fig. 2-1).   
 
2.3.2  Expression levels of CasEcRs and CasRXRs during ovarian 
development and embryogenesis 
 
 a) Total CasEcRs 
 Ovary and embryo samples contain different levels of CasEcRs 
expression: ovary tissue shows 10-50 times higher levels than those of embryo 
tissue (Fig. 2-2).  During the ovarian development from stage 1 to 4, there is no 
marked difference in the CasEcRs expression: 8.4 ± 0.5 x105 copies/µg total 
RNA (n=3) at stage 1; 10.9 ±1.8 x105 copies/µg total RNA (n=6) at stage 2; 7.1 ± 
1.2 x105 copies/µg total RNA (n=7) at stage 3; and 6.2 ± 2.8 x 105 copies/µg total 








Figure 2-2.   Levels of total CasEcR expression during ovarian and embryonic 
development of C. sapidus by qRT-PCR assays.  Sample cDNAs (25 ng total RNA eqv.) 
of ovaries (n=4) and embryos (n= 5-10).  The data are presented as mean ± SE 
copies/µg total RNA.  All data were subjected to a normal distribution using the Shapiro-
Wilk test (SigmaPlot).  When the data did not show the normal distribution, a 
nonparametric test (Mann-Whitney Rank Sum test) was employed.  Statistical 
significance was accepted at P < 0.05 and noted with letters at each developmental 
stage.  N.D= no statistical difference 
 
  
 The levels of CasEcRs change during embryogenesis.  At the yolk stage, 
levels of CasEcRs were measured at 2.1 ± 0.4 x104 copies/µg total RNA (n=11) 
and start to rise at the limb-formation stage (0.7 ± 0.2 x105 copies/µg total RNA, 
n=12).  At the eye-anlage stage, the expression of CasEcRs is elevated to 1.1 ± 
0.3 x105 copies/µg total RNA (n=9).  However, these levels begin to decline to 
0.9 ± 0.5 x105 copies/µg total RNA (n=7) at the heart-beat stage, continuing to 
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drop to 0.4 ± 0.2 x105 copies/µg total RNA (n=5) and 0.1 ± 0.1 x105 copies/µg 
total RNA (n=5) at both the developing-eye and hatching-imminent stage, 
respectively.  In zoeae, the expression of CasEcRs is measured at 0.2 ± 0.1 x105 
copies/µg total RNA (n=5). 
 
 b) Total CasRXRs 
 Similar to the expression of CasEcRs, the levels of CasRXRs in ovaries 
are ~10 times higher than the embryos (Fig. 2-3).  The expression of CasRXRs 
during ovarian development remains constant, ranging from 6.3 ± 0.9 (x105 
copies/µg total RNA, n=3) at stage 1; 6.9 ± 1.1 x105 copies/µg total RNA (n=6) at 
stage 2; 5.5 ± 0.7 x105 copies/µg total RNA (n=7) at stage 3; and 6.2 ± 1.1 x105 






Figure 2-3.   Levels of total CasRXR expression during ovarian and embryonic 
development of C. sapidus by qRT-PCR assays.  Sample cDNAs (25 ng total RNA eqv.) 
of ovaries (n=4) and embryos (n= 5-10).  The data are presented as mean ± SE 
copies/µg total RNA.  All data were subjected to a normal distribution using the Shapiro-
Wilk test (SigmaPlot).  When the data did not show the normal distribution, a 
nonparametric test (Mann-Whitney Rank Sum test) was employed.  Statistical 
significance was accepted at P < 0.05 and noted with letters at each developmental 
stage.  N.D= no statistical difference 
 
  
 Similar to the expression pattern of CasEcRs, the levels of CasRXRs are 
as low as 0.2 ± 0.1 x105 copies/µg total RNA (n=8) at the yolk stage.  At the limb-
formation and eye-anlage stages, levels of CasRXRs are significantly (P<0.05) 
increased to 0.6 ± 0.1 x105 copies/µg total RNA (n=8) and peaked to 0.7 ± 0.1 
x105 copies/µg total RNA (n=10), respectively.  After the heart-beat stage, levels 
of CasRXRs are reduced from 0.5 ± 0.2 x 105 copies/µg total RNA (n=7), to 0.2 ± 
 
0.1 x 105 copies/µg total RNA (n=5) at the developing
x 105 copies/µg total RNA (n=5) at the hatching
contained levels of CasRXRs
  




 The full-length cDNA sequence (1,650 nt) of 
accession no. KC736588) includes 204 nt of 5´untranslated region (UTR), 948 nt
of the open reading frame (ORF), and 495 nt of 3´UTR
 
 
Figure 2-4.   Schematic diagram of 
(CasBTBDP: accession no. KC736588) and its putative regulatory elements analyzed 
using Regulatory RNA analysis program 
in 5´UTR.   
 
 
 The putative protein encoded in ORF contains BTB domain and is 
identified as a member of BTB superfamily.  The putative 
protein (CasBTBDP) shows the highest sequence identity (72%) with BR
crustacean species P. monodon,
mori, Apis mellifera, and 
putative CasBTBDP does not contain a zinc
-eye stage, and to 0.4 ± 0.2 
-imminent stage.  Hatching zoeae 
 with 0.1 ± 0.1 x 105 copies/µg total RNA (n=4)
BTB domain protein of C. sapidus 
CasBTBDP (GenBank 
 (Fig. 2-4).  
 
BTB domain protein cDNA isolated in 
[155].  Post transcriptional control is predicted 
C. sapidus
 and followed by those from insect species: 
T. castaneum with 51, 50, and 47%, respectively.  The 







 BTB domain 





2-4 and 2-5).  As shown in Fig. 2-4, two putative translational, regulatory 
elements are predicted in the 5´UTR: internal ribosome entry site (IRES: C4-G99 
and G167-G258) and an upstream ORF (uORF: A54-A146).    
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Trc           1 --MVDTQHFCLRWNNYQSSITSAFENLRDDEDFVDVTLACDGKSLKAHRVVLSACSPYFRELLKSTPCKHPVIVLQDVAW 
Apm           1 --MVDTQHFCLRWNNYQSSITSAFENLRDDEDFVDVTLACDGRSLKAHRVVLSACSPYFRELLKSTPCKHPVIVLQDVAF 
Bom_Z1        1 MVDSQTQHFCLRWNNYQRSITSAFENLRDDEDFVDVTLACDGKSLKAHRVVLSACSPYFRELLKSTPCKHPVIVLQDVAY 
Pem_6.2       1 ---MEEGYLALRWNNHNTIFTKILTLLREQEAYVDVSLACAGRLYPAHKFVLSTCSEYFKEMFSKNPCKHPIVFMKDVST 
Pem_6.1       1 ---MEEGYLALRWNNHNTIFTKILTLLREQEAYVDVSLACAGRLYPAHKFVLSTCSEYFKEMFSKNPCKHPIVFMKDVST 
Cas           1 ---MTDELLSLKWNNHKSTFADILTILRDQEVFIDVTLACGGKQYPAHKFVLSTCSDYFKEMFTKNPCKHPIVFMKDVSA 
Pem_4         1 ---MEDGLLSLKWNNHKTTFFEILRVLREKANYTDATIAVDGKFYPVHKLVMSTCSEYFSEIFEKTPCKSPVIVLKDVRS 
 
 
Trc          79 TDLHALVEFIYHGEVNVHQRSLSSFLKTAEVLRVSGLTQQHGD-DREQLAQVQSLVRSQQSTPTSNHHPSFTEKLVEDAL 
Apm          79 SDLHALVEFIYHGEVNVHQRSLSSFLKTAEVLRVSGLTQQADQTDRDELSHVRALAAGGNHLP---FHEKLVESFPRGGS 
Bom_Z1       81 TDLHALVEFIYHGEVNVHQHSLSSFLKTAEVLRVSGLTHNDAA-QGPLLQTMRSSAAPSPHTPPHPAHSTHIPQPYPDKL 
Pem_6.2      78 KDMEALLDFMYKGEVHVPQSELGSLLRTAEGLQVKGLAVPDDSPRGSSTTPIVPSASSVPRSPPPSLMAPMHMRGKRKRP 
Pem_6.1      78 KDMEALLDFMYKGEVHVPQSELGSLLRTAEGLQVKGLAVPDDSPRGSSTTPIVPSASSVPRSPPPSLMAPMHMRGKRKRP 
Cas          78 RDLEALLDFMYRGEVNVPHHNLASLIKTAEGLQVKGLAVPDD---------------------------PVQLRKAEPRS 
Pem_4        78 QDMEALLDYMYLGEVNVNQNDLASLLKTAECLRIKGLAVPDED------TTKVRKAPPDDRQESPPPKRRRNEDNPSSAP 
 
 
Trc         158 FTSPSSPPHGATVNQLLRRAALQHRRERRISSDPEGDHKRPRPDHIIGNNNNNELNLSHTQPPQTQPADFSPSAMKNNAL 
Apm         156 LPTPVTPTP--TTVQQLLRRAQIRRNERRTPDPHDETAKKPRVLSPPLNNND---------------------------- 
Bom_Z1      160 EEALLQPSS--SIPPMMRRIPLPPPRRMSSTDNSPDVIKRPRHDNNNTESPQ---------------------------- 
Pem_6.2     158 PESAKKDDPPKLTLRPDLGPPATNRSRMRNRPPGMPELKRIKREERNAANVG---------------------------- 
Pem_6.1     158 PESAKKDDPPKLTLRPDLGPPATNRSRMRNRPSGMPELKRIKREEHSAANVG---------------------------- 
Cas         131 RE-LRETHTPRPPPEPSASPP--------------PKKKRTREPEHVSERMT---------------------------- 
Pem         152 RPVSPSVNAPSKTTTPSVTPPVQSAS--------LPGSQSQDGIQDSSLDVP---------------------------- 
 
 
Trc         238 NLNMNSSSTTTTQNEANNGITSTERENSPCSPSPTLNSRLNEENVKSEPMELLCSTNQEENSNDSGDVANDNGPNNLPQG 
Apm         206 -----ATPTDFSMGVKNNHVSSKVEGNGVHEENSPLEDNIKCEPLELTGGNSGNAAGNNEDSSDSGAAASDRPP------ 
Bom_Z1      210 -MHAADFSTKNHSILNSRGHEQGNNGNGISNSSSSPSPRLMDEVKNEPVDMICPSNPDIDRCTDDTPPHTHHRPIGGPPS 
Pem_6.2     210 ---------TIEPGEVPGSPSPTPSSHNSDEQSQNLAHKIKTERSEYSKEEAEDLDEDEGVAGEVMSGEEEQEQEPEEEE 
Pem_6.1     210 ---------TIEPGEVPGSPSPTPSSHNSDEQSQNLAHKIKTERSEYSKEEAEDLDEDEGVAGEVMSGEEEQEQEPEEEE 
Cas         168 ---------TLYGNMSPHHEPNSP-------------YDLSQKSSSSSVSQSDNLHNDTAAPNPMSPDQPPSHQHPVHHH 
Pem         196 ---------PMVKVEMQEADDPDDYRKDNSYEGGSVNEGEMGSDFGAELSKAEHDPDSYGSGSYAGPSIQPGGDLPWDEG 
 
 
Trc         318 PHSGSSAG--------------------DHDEHDSPIGPYLTPSESKLFATAAGSFNFSMAALAADPTGLGGLN--QSLQ 
Apm         275 --ASASSN--------------------EHEAESEHTSTPNFLSEAKIFPPTPGSFNFSMAALATEHTPLSVKFPGMGHG 
Bom_Z1      289 RSSSADAE--------------------DRTPPPQLPPSPFIPPPDTKLFNPSNSYNFTMEALAQHSTLAGLQSPLASDG 
Pem_6.2     281 EEEEEEEEEGALGEGEGLSHGVLSDVEDGYEQSNSSLPNSDISTTELLQVDLSEDGTQFIIGPGGFGDMMSRTSSLAGDD 
Pem_6.1     281 EEEEEEEE-GALGEGEGLSHGVLSDVEDGYEQSNSSLPNSDISTTELLQVDLSEDGTQFIIGPGGFGDMMSRTSSLAGDD 
Cas         226 QQHLANKE-------------------------------------------------------------------NSPDD 
Pem         267 DSSSFPQE--------------------GFSGDLPAGQQPQGDWDHVRPAALIPVVEIRQPVAASTPTSIAQLMTGACPK 
 
 
Trc         376 ANADSLAGTSQESSGGG-----------------RPGRTAFCDICNKTFSRFWSLQRHLSDTHFYTPQNLQCNVCGRSYR 
Apm         333 LQPPDLAGTSQGSAGLPSAILAMRLSHPLHGNLLPPGVCYTCDVCGKTLSTKLTLKRHKEQQHFQPLNSAVCALCHKVFR 
Bom_Z1      349 MASTSQGGAR------------------------TPQEDYRCDPCNKSLSSLTRLKRHIQNVHMRPSREPVCNICQRVYS 
Pem_6.2     361 ERNGDKEQKKPFVCPLCGQSFTRRDNLANHIKTHTGDRPFMCQYCHKCFSRKDYLKQHERI--HTGEKPYPCDICGRAFT 
Pem_6.1     360 ERNGDKEQKKPFVCPLCGQSFTRRDNLANHIKTHTGDRPFMCQYCHKCFSRKDYLKQHERI--HTGEKPYPCDICGRAFT 
Cas         239 TRRVSSTPQPPTPQPLPPKSPLP--------------------------LASSEVNCQEKS--HEEADPMPGPSWRPVAT 
Pem         327 TAAIPMGPASGAFTPYTASTSPRGSTPDLAQVAPADKQSFMCPVCGKQFGQPYNLRRHLTT--HTGERPYRCPHCNYAAS 
 
 
Trc         439 SRNSLVSHRSQYHREGNEIKFENDCFI--------------- 
Apm         413 TLNSLNNHKSIYHRRQK------------------------- 
Bom_Z1      405 SLNSLRNHKSIYHRKQPAPPAPGPFYPVN------------- 
Pem_6.2     439 RKEGLTDHMRCHSDFRAFSCETCGKSFKQKCGPRFHKRNYKH 
Pem_6.1     438 RKGGLTDHMRCHSDFRAFSCETCGKSFKQKCGLRFHKRNYKH 
Cas         291 KPEDEVVS---------------------------------- 
Pem         405 QNVHLEKHIRRIHLNNGQNETPTGPAVTWAPAATAVTP---- 
 
Figure 2-5.    Multiple alignment of BTBDP in C. sapidus (Cas), and BTB domain protein 
from other arthropods: A. mellifera (Apm: NP_001035356.1), B. mori (Bom _Z1: 
NP_001104804.1), P. monodon (PemBR-C: Pem_4: JN638741.1; Pem_6.1: 
JN638739.1; Pem_6.2: JN638740.1), and T. castanaum (Trc: NP_001104734.1) using 
ClustalW (http://www.ebi.ac.uk) website and Boxshade server 




represent the highly conserved residues among the analyzed sequences.  Putative zinc 








 As shown in Fig. 2-6, during ovarian development, levels of CasBTBDP 
expression are high and remain constant ranging from 6.3 ± 0.9 x105 copies/µg 
total RNA (n=4) at stage 1; 11.7 ± 5.3 x105 copies/µg total RNA (n=4) at stage 2; 
10.6 ± 3.0 x105 copies/µg total RNA (n=4) at stage 3; and to 11.2 ± 2.7 x105 
copies/µg total RNA (n=2) at stage 4.  During embryogenesis, these levels are 
low with 0.3 ± 0.1 x105 copies/µg total RNA at the yolk stage (n=7) but rise to 1.1 
- 1.4 x105 copies/µg total RNA (n=6-7) from the limb-formation to the hatching-
imminent stages, without showing a statistically significant difference (P<0.05).  
Hatching zoeae show levels of CasBTBDP expression with 0.6 ± 0.1 x105 





Figure 2-6.   Expression levels of CasBTBDP by qRT-PCR assays during ovarian and 
embryo development of C. sapidus.  Sample cDNAs (25 ng total RNA eqv.) of ovaries 
(n=4) and embryos (n= 5-10) at each particular stage.  The data are presented as mean 
± SE copies/µg total RNA.  All data were subjected to a normal distribution using the 
Shapiro-Wilk test (SigmaPlot).  When the data did not show the normal distribution, a 
nonparametric test (Mann-Whitney Rank Sum test) was employed.  Statistical 




2.3.5  CasCHH and  CasMIH expression  
 The patterns of CasCHH and CasMIH expression in this study during 
embryogenesis are similar to the total ecdysteroids and ecdysteroid-responsive 
factors, especially in CasCHH (Fig. 2-7).  At the early stages (yolk and limb-
formation), CasCHH is detected with 610 ± 16 (n=8) and 710 ± 24 (n=10) 




copies/µg total RNA (n=10, P<0.05) at the eye-anlage stage and to 2.6 ± 0.4 
x104 copies/µg total RNA (n=9, P<0.05) at the heart-beat stage.  CasCHH levels 
peak at the developing-eye stage (5.0 ± 1.2 x104 copies/µg total RNA, n=6).  The 
levels decline at the hatching-imminent stage: copies/µg total RNA 2.8 ± 0.6 
(n=6) and remain low at the zoeal stage: 2.0 ± 0.4 x104 copies/µg total RNA 
(n=3).   
  
 
Figure 2-7.   Expression levels of CasCHH during eyestalk organogenesis in C. sapidus 
embryos.  Each cDNA sample containing 25 ng total RNA eqv. was assayed in 
duplicate.  The expression levels are represented as copies/µg total RNA.  The data are 
presented as mean ± SE (n).  All data were subjected to a normality test using the 
Shapiro-Wilk test (SigmaPlot).  When the data did not show the normal distribution, a 
nonparametric test (Mann-Whitney Rank Sum test) was employed.  Statistical 
significance was accepted at P < 0.05 and noted with letters.   
 
 CasMIH levels do not fluctuate as we also found in CasCHH (Figs. 2-8).  
During yolk and eye-anlage stages, the levels of CasMIH are similar, ranging 
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between 4.3 - 7.3 x 103 copies/µg total RNA (n=5-6); however, the levels 
significantly increase to 2.3 ± 0.6 x104 copies/µg total RNA (n=6, P<0.05) at the 
heart-beat stage and 2.2 ± 0.6 x104 copies/µg total RNA (n=8) at the developing-
eye stage, compared to those measured at earlier developmental stages.  Then, 
the CasMIH levels drop to 1.2 ± 0.3 and 1.1 ± 0.3 x104 copies/µg total RNA (n=5-
6) at the hatching-imminent and zoeal stages, respectively. 
 
 
Figure 2-8.   Expression levels of CasMIH during eyestalk organogenesis in C. sapidus 
embryos.  Each cDNA sample containing 25 ng total RNA eqv. was assayed in 
duplicate.  The expression levels are represented as copies/µg total RNA.  The data are 
presented as mean ± SE (n).  All data were subjected to a normality test using the 
Shapiro-Wilk test (SigmaPlot).  When the data did not show the normal distribution, a 
nonparametric test (Mann-Whitney Rank Sum test) was employed.  Statistical 





2.3.6  Localization of C
 The presence of CasCHH and CasMIH is noted in embryos at the heart
beat stage of the C. sapidus
intensity is stronger in the sinus gland than in the cells.  Similar to the expression 
patterns as shown in Fig. 
show greater staining intensity in the sinus gland than those at the heart
stage (Fig. 2-9C).  However, there is no difference between the neuropeptides: 
CasCHH and CasMIH at the same embryonic stages. 
 
 
              
   
B) 
A) 
asCHH and CasMIH during eyestalk formation
 embryos (arrow in Figs. 2-9A and B): staining 















Figure 2-9.  Immunolocalization of CasCHH (A) and CasMIH (B) in the embryos at 
heart-beat and developing-eye stages.  The insets show the magnification of the X-
organ (XO).  C) The analysis of staining intensity and area of CasCHH and MIH of the 
sinus gland of embryos at heart-beat and developing-eye stages (ImageJ).  Statistical 
significance (P<0.01) between the two stages was noted with ** for CasCHH (closed 
bar) and CasMIH (open bar).  No difference was found between the neuropeptides: 
CasCHH and CasMIH at the same embryonic stages.  The number of adult females are 
noted in the graph.  Arrows indicate axonal tracts; SG= sinus gland.  Scale bars are 







































 Our study shows the profiling of changes in the titers and transcriptional 
levels of major molt regulators: ecdysteroids and their receptor (CasEcRs and 
CasRXRs) and two neuropeptide hormones (CasCHH and CasMIH) during the 
ovarian development and embryogenesis of C. sapidus.  In addition, we isolated 
the full-length cDNA sequence of C. sapidus BTB domain protein (CasBTBDP), 
as well as quantified for temporal changes along with these molt regulators. 
 
 The somatic growth of arthropods requires molting processes, which are 
coordinated by ecdysteroids and precisely-timed pulsatile release of 
neurohormones [35,38,60,135].  Ecdysteroids produced and secreted by the Y-
organs in crustaceans or prothoracic glands in insects trigger these animals to 
enter and to prepare for the premolt as well as initiate embryogenesis.  Prior to 
organogenesis of Y-organs or prothoracic glands, ecdysteroids are derived from 
the mother as conjugated to a large amount of vitellin (VT) [94,156,157].  From 
the phosphorylated-inactive forms conjugated to VT in the ovary, maternal 
ecdysteroids are being released via VT utilization at the initiation of 
embryogenesis [158].   
 The increase of ecdysteroid levels in the occytes is comparable to the VT 
contents that is reported in developing ovaries of C. sapidus [89].  Our current 
results are similar to the findings reported in several crustacean species including 
C. maenas, M. rosenbergii, Orchestia gammarella and Lysmata seticaudata, 
where the levels of ecdysteroids are parallele to those of vitellogenesis 
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[95,105,133,159-163].  As stated above, vitellogenin is suggested to carry 
ecdysteroids to the ovary of crustaceans.  By contrast, some insect ovaries 
synthesize ecdysone [164,165], the function of which is known to stimulate 
vitellogenesis in fat body and follicle cells of the mosquito, Aedes aegypti 
[166,167].  The direct involvement of ecdysteroids in vitellogenesis itself has not 
yet been defined in decapod crustaceans.  The maternal ecdysteroids that are 
accumulated in the oocytes during ovarian development of C. sapidus may 
trigger the initiation of embryogenesis, as in D. melanogaster [156].    
 Levels of ecdysteroids change during C. sapidus embryogenesis (Fig. 2-
1), implying their functional importance in embryogenesis.  The accumulation of 
ecdysteroids in the developing ovaries noticeably correlates with ovarian 
development, specifically with the amount of VT in the ovary [89], suggesting that 
CasVT serves as a carrier protein, similar to what is reported in insects such as 
B. mori, Dacus cucurbitae and D. melanogaster [94,156,157].  Hence, the 
maternal ecdysteroids released from VT through the utilization of CasVT may be 
responsible for the changes in ecdysteroid levels in early C. sapidus 
embryogenesis, particularly at the yolk stage, which is similar to what is reported 
in B. mori and D. melanogaster [94,156]. 
 The levels of ecdysteroids in C. sapidus embryos are akin to those of 
other crustaceans and insects, ranging between 2-80 pg/embryo, which reflect 
the size of embryos [94,100,105,161,168-170].  Interestingly in this study, as the 
C. sapidus embryo begins to develop, ecdysteroid levels are reduced.  This 
finding is similar to the earlier observation in the B. mori embryogenesis when the 
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ecdysteroid levels abruptly decline during cell differentiation [158].  The 
continuous utilization of VT during embryogenesis indicates the release and use 
of maternal ecdysteroids.  Hence, this condition may result in the reduced levels 
of total ecdysteroids seen during early embryogenesis.   
 The overall patterns of the changes in embryonic ecdysteroids in later 
stages are similar to those seen in the juvenile molt [37,119].  Levels of 
ecdysteroids are low at early embryogenesis, then increased to peak, and 
returned to the low levels, before hatching of the embryos.  The increase in 
ecdysteroid levels at the limb-formation stage of C. sapidus embryogenesis may 
reflect the organogenesis and activity of Y-organs.  This notion is supported by 
which levels of cholesterol are gradually reduced during C. sapidus 
embryogenesis (Prof. R. Lee, personal communication).  The presence of Y-
organs that were observed at the limb-formation stage of P. serratus embryos 
coincides with the increase in the total ecdysteroids [100,137].  However, in 
Machrobrachium rosenbergii, increase in ecdysteroid levels occurs at the eye-
anlage stage [105], indicating that the timing of organogenesis of Y-organs may 
somewhat differ in this species.  Taken together, it is suggested that the increase 
in ecdysteroids during C. sapidus embryogenesis may be primarily contributed to 
de novo synthesis from the developing Y-organs.  
 Changes in ecdysteroid levels during ovarian development and 
embryogenesis may often forecast the differences in the amounts of EcRs and its 
responsive factors.  However, ovaries contain levels of CasEcR, CasRXR, and 
CasBTBDP expression 10-50 times higher than embryos, contrary to the 
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ecdysteroid patterns.  Such high expression levels of these genes in ovaries 
indicate that maternal CasEcR, CasRXR, and CasBTBDP may be immediately 
translated at early embryogenesis when transcription machinery may not be yet 
functional [171,172].  Subsequently, these results imply that the ecdysteroid 
receptor complex (CasEcR-CasRXR) and CasBTBDP may be involved in the 
early embryogenesis of C. sapidus.   
 Compared to the juvenile molt, the pattern changes of embryonic 
ecdysteroids, and the receptor complex (CasEcR-CasRXR) we observed are 
similar to those of the hemolymph and Y-organ, respectively [119].  In embryonic 
development, levels of both CasEcR and CasRXR are peaked earlier than that of 
the ecdysteroids.  Up-regulation of EcR and RXR by ecdysteroids that occurs in 
prothoracic gland of M. sexta further modulates this gland’s activity for 
ecdysteroid synthesis [10,173,174].  Therefore, we infer that ecdysteroids may 
be responsible for controlling the newly formed Y-organ in the embryos for 
ecdysteroidogenesis.  Our data imply that ecdysteroids and their receptors in C. 
sapidus embryos may have similar functions in the juvenile molt.   
 BTBDPs, with BTB domain for a protein-protein interaction motif, share a 
function in protein degradation by ubiquination [175,176].  Particularly, in the 
embryos of Caenorhabditis elegans and D. melanogaster, ubiquitination through 
BTBDP is required for degradation of various cell cycle regulators such as 
CDC25 and cyclin D, and hedgehog morphogen [177]; Zhang, 2006 #494].  
Thus, we infer that CasBTBDP may have a similar function in C. sapidus as in C. 
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elegans and D. melanogaster, because its expression levels are maintained high 
in oocytes and embryos.   
 During early developmental stages (yolk and limb-formation stages), 
transcriptional levels of CasMIH are higher than those of CasCHH.  Our result is 
somewhat contradictory to earlier reports that MIH levels are much lower than 
CHH in embryo and adult C. maenas as well as in the eyestalk ganglia of juvenile 
and adult C. sapidus [23,44,178].  In C. sapidus, CasMIH expression is detected 
in the ovary and even prior to the eye anlage stage when CasCHH expression is 
also seen.  In C. maenas, the expression of CHH and MIH is seen only at the 
eye-anlage stage but not in mature oocytes [98].   
 These observed differences in the timing of occurrence and levels of MIH 
suggest that the expression pattern of MIH may be species-specific, due to their 
different life histories and ecological conditions.  In particular, C. sapidus inhabits 
relatively warmer water temperature than C. maenas, which affects the overall 
duration of embryogenesis, particularly initiation at the yolk stage.  Therefore, we 
suggest that the regulatory mechanism of MIH expression during embryogenesis 
of C. maenas and C. sapidus may be slightly different.  We are currently 
investigating the presence of ovarian MIH to see if its cDNA is identical to that 
found in eyestalk ganglia in juveniles and adults of C. sapidus.  
 The overall patterns we observed of CasCHH and CasMIH expression in 
the eyestalk ganglia mirror the changes of ecdysteroids.  Interestingly, the 
changes in CasCHH and CasMIH expression during embryogenesis seem 
comparable to and similar to changes seen in the juveniles where the amounts of 
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these neuropeptide expressions are closely related to the measured ecdysteroid 
titers (unpublished data).  With this new data and our findings of the current 
study, we infer that CasCHH and CasMIH transcription and their hormonal levels 
may be affected by the presence and amount of ecdysteroids.  Our finding 
suggests that the developing eyestalk during embryogenesis seems to have 
activity similar to that in the juvenile crabs; therefore, these neuropeptide 
hormones may function as molt regulator during C. sapidus embryogenesis.   
 Molting results in the increase in the somatic size.  Also noteworthy is that 
there is a difference in the size of decapod crustacean embryos at spawning and 
just prior to hatching.  Similar to the juvenile and adult molt, the hatching process 
also relies on the uptake of iso-osmotic water that is assisted by the complete 
discharge of CHH produced by abdominal cells in C. maenas [118] and C. 
sapidus (unpublished observation).  This increase in the size of embryos may be 
attributed to the first molt that is initiated by maternal ecdysteroids and occurs 
within the embryonic envelopes without shedding.   
 Zygotic ecdysteroids produced by developing Y-organs, as well as CHH 
and MIH generated in the developing-eyestalk ganglia, may interact and control 
both the hatching and molting processes.  Although the exact timing of the first 
molt cycle driven by zygotic ecdysteroids is unknown, we suggest that the first 
molt cycle can be noted by the presence of CHH expression located in the 
abdominal segments of C. sapidus (unpublished data) and C. maenas embryos 
[98], equivalent to gut CHH endocrine cells in adults, occurring only ~ 5-7 days 
prior to hatching.   
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 Together with the presence of ecdysteroids and related expression of 
ecdysteroid-responsive factors, we believe that the process of embryos hatching 
to zoeae accompanying with the cuticular shedding is the first molt of C. sapidus.  
Our data demonstrate the presence of ecdysteroids, their receptors, and both 
CHH and MIH during the ovarian development and embryogenesis in C. sapidus.  
An inter-relationship between ecdysteroids and the expression of neuropeptides, 
specifically MIH, still remains to be studied.  Since genomic sequences of Cancer 
pagurus, and Charybdis feriatus MIH contain the binding sites for BR-C, E74A 
and RXR in the upstream promoter region, we are currently gathering the 





3. CHAPTER 3   
Ecdysteroids induce the expression of molt-inhibiti ng hormone 




 Arthropod molt is coordinated through the interplay between ecdysteroids 
and neuropeptide hormones.  In crustaceans, changes in the activity of Y-organs 
during the molt cycle have been regulated by molt-inhibiting hormone (MIH) and 
crustacean hyperglycemic hormone (CHH).  Little has been known on the mode 
of direct effects of ecdysteroids on the levels of MIH and CHH in the eyestalk 
ganglia during the molt cycle.  This study focused on a putative feedback of 
ecdysteroids on the expression levels of MIH using in vitro incubation study with 
ecdysteroids and RNAi in the blue crab, Callinectes sapidus.  Our results show a 
tissue-specific expression of ecdysone receptor (EcR) in which the major isoform 
in eyestalk ganglia is EcR1.  The initial elevation of MIH expression at the early 
premolt stages is replicated by in vitro incubations of ecdysteroids that mimic the 
intrinsic conditions of D0 stage, in terms of the concentration (75 ng/ml) and the 
composition (ponasterone A and 20-hydroxyecdysone at a 3:1 ratio).  
Additionally, multiple injections of EcR1-dsRNA reduce MIH expression by 67%, 
compared to the controls.  Our data provide evidence on a putative feedback 
mechanism of hormonal regulation in molting, specifically how the molt cycle may 
be repeated during the life cycle of crustaceans.  The elevated concentrations of 
ecdysteroids at premolt stage may positively act on the expression levels of MIH 
in the eyestalk ganglia.  Subsequently, the increased MIH titers in the 
52 
 
hemolymph at postmolt may inhibit the synthesis and release of ecdysteroids by 
Y-organs, re-setting, succeeding and subsequently, recapitulating the molt cycle.    
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3.1  Introduction  
 Endocrine systems normally have feedback controls to regulate their 
balance in the organisms.  In vertebrates, steroid hormones such as estrogens, 
glucocorticoids, and androgens regulate their production through negative 
feedback on neuroendocrine axes [31].  In insect neuropeptides, 
prothoracicotropic hormone (PTTH) that is produced from the brain and released 
by corpora cardiaca stimulates the prothoracic gland for ecdysteroidogenesis.  
PTTH is positively regulated by the ecdysteroids in Manduca sexta [24-27].  The 
ecdysteroids also generate short-loop feedbacks on prothoracic gland: 
stimulating at lower levels while inhibiting at the higher titers as reported in M. 
sexta and Pieris brassicae [10,30-32].   
 Life stages of arthropods continue through the recapitulated molting 
process.  Molting is complex mechanisms that are hormonally regulated and 
involves in cell division, synthesis and deposition of new cuticle thereafter 
shedding of the old shell [36,179,180].  In crustaceans, members of the 
crustacean hyperglycemic hormone (CHH) family that are originated from the 
major endocrine tissue, eyestalk ganglia (X-organ-sinus gland) located within the 
eyestalk, are involved in the regulation of molting: 1) CHH and 2) molt-inhibiting 
hormone (MIH) [34-36,38,60].  MIH and CHH suppress the synthesis and release 
of ecdysteroids by Y-organs [178,181].  The hemolymph concentrations of CHH 
and MIH are closely associated with the levels of ecdysteroids during the molt 




 Ecdysteroids, arthropods’ molting hormones, are secreted by crustacean 
Y-organs that are equivalent to insect prothoracic glands.  The levels of 
hemolymphatic ecdysteroids are positively related to molt stages in the following 
decapod crustaceans including Cancer magister, C. maenas, Callinectes 
sapidus, Daphnia magna, Hyas araneus, Homarus americanus, Metopograpsus 
messor, and Procambarus clarkii [3-7,9,59,182].  Y-organs secrete inactive forms 
of ecdysteroids: ecdysone, and 25-deoxyecdysone (25-dE) [43,49-51] that are 
subsequently hydroxylated at the peripheral tissues to active forms: 20-
hydroxyecdysone (20-HE) and ponasterone A (PoA), respectively 
[52,57,183,184].  20-HE is known to be the main active ecdysteroid in insects.  
However, the hemolymph of a given crustacean species carries more than one 
active form.  In the premolt hemolymph of C. sapidus and C. maenas, PoA is 
measured as the major type of ecdysteroid and then 20-HE as the second 
[9,60,183].  
 Ecdysteroids have been known to affect the activity of Y-organs as well as 
that of the eyestalks [14,28].  20-HE influences the Y-organ activity of 
Orconectes limosus positively or negatively depending on its concentrations 
[185], while a putative positive feedback of ecdysteroids on eyestalk 
neuropeptides is suggested in Cancer antennarius [39].  Interestingly, at premolt 
stages, the concentrations of ecdysteroids are changed, as well as the ratio 
between the two active forms.  At the mid-premolt stage (D2) of C. sapidus, the 
amounts of PoA to 20-HE are observed at a 3:1 ratio [60].  To date, it has not yet 
been studied in decapod crustaceans how such inherent changes in ecdysteroid 
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titers and the ratio between PoA and 20-HE may affect the transcription and 
translation of MIH/CHH in the eyestalk ganglia during the molt cycle.   
 In addition to the presence of two active ecdysteroids in C. sapidus, most 
of the internal tissues of this species express multiple CasEcRs [119].  
Specifically, CasEcR1 distinguishes from CasEcR2, as the putative ligand 
binding pocket (LBP) of the former contains more hydrophilic amino acids (aa) 
than those of the latter.  Such difference in hydrophobicity may play an important 
role in a ligand specificity and affinity to a particular type of ecdysteroids.  
However, it has not yet been examined that the elevated levels of total 
ecdysteroids or a specific type of ecdysteroid may influence in the expression 
levels of EcR in relation to the molt regulation of decapod crustaceans.  
 In this study, we aimed to better understand the hormonal regulation of 
molting that recapitulates throughout the life cycle of arthropods using the 
hatchery-raised blue crab, C. sapidus with tractable life and molt stage as a 
model animal.  Specifically, to define a putative feedback mechanism, we 
focused on the interplay between two endocrine systems involving CasMIH from 
eyestalk ganglia and ecdysteroids from Y-organs.  We first examined to test if 
ecdysteroids influence the expression of CasMIH in eyestalk ganglia using an in 
vitro incubation.  We then also determined the effect of multiple injections of 






3.2.  Materials and methods 
3.2.1 Animals and sample collections 
 Male and female young juvenile C. sapidus (20-40 mm carapace width, 
CW) obtained from blue crab hatchery, Aquaculture Research Center (ARC, 
Institute of Marine and Environmental Technology, Baltimore, MD, USA) were 
reared in the same conditions as stated [119] until they reached the size of 50-90 
mm CW (crab stage 13-16 [114]).  Molt stages of these animals were 
determined: intermolt (C4), and premolt (D0-D3-4) stages as stated [114].  After the 
collection of hemolymph as described [119], the animals were placed on ice for 
5-10 min prior to dissection.  Eyestalk ganglia and Y-organs were microscopically 
collected and frozen immediately on dry-ice.  The samples were stored at -80oC 
until further use.  
 
3.2.2  Temporal-spatial distributions of ecdysone r eceptor ( CasEcR) 
isoforms in eyestalk ganglia and Y-organs at differ ent molt stages 
 
 
 Tissues were collected from three animals at the following molt stages: 
intermolt: C4, early premolt: Do, mid-premolt: D1-D2, and late premolt: D3-4.  
Tissues were homogenized with 150 µl ice-cold DEPC treated PBS and 100 µl of 
homogenized samples were subjected to total RNA extraction, as described 
[119,153].  After treating with DNase I (Fermentas), the total RNAs (1.5 µg) were 
subjected to the 1st stranded cDNA synthesis using RevertAid Reverse 
Transcriptase (Fermentas).  The cDNA samples were diluted to the final 
concentration at 12.5 ng total RNA/µl equivalent.  Each sample cDNA (12.5 ng 
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total RNA equivalent) was examined using an end-point RT-PCR assay with 
GoTaq® Green Master Mix (Fermentas) and isoform-specific primers at the 
following PCR condition: initial denaturation at 94°C for 3 min; 30 cycles at 94°C 
for 30 s, 58°C for 30 s, and 72°C for 30 s; and a f inal extension at 72°C for 7 min 
(Table.3-1).  The PCR products were run on a 1.5 % agarose gel and were 
documented using a Kodak gel-documentation system.  The Results shown in 
Figs. 3-6A and B were the representative pictures of three independent assays.  
 
 
3.2.3  Effects of in vitro incubations of ecdysteroids on CasMIH expression 
in eyestalk ganglia 
 
 
 The animals (80-90 mm CW) at intermolt were ice-chilled; the eyestalks 
were dissected under a dissection microscope; and, the retinas were removed 
carefully and rinsed with ice cold DEPC-treated crustacean saline (pH 7.4).  The 
eyestalks were pre-incubated in DEPC-treated crustacean saline, 0.05% M199 
media (incubating media) for 30 min at room temperature for pre-conditioning to 
an experimental condition.  After being rinsed with the incubating media again, 
the eyestalks were then incubated with the incubating medium containing PoA 
and 20- 20-HE at a 3:1 ratio.  These concentrations (75, 150, and 250 ng/ml) of 
ecdysteroids for the incubation studies were chosen, based on the levels of 
intrinsic circulating ecdysteroids at Do, D1, and D2 stages, as reported in C. 
sapidus [60,119].  The eyestalk ganglia were incubated on a shaker (30 rpm) for 
3 hrs at 23-25oC.  The incubated eyestalk ganglia were rinsed twice with DEPC-
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treated crustacean saline, blotted on a Kimwipe to remove the saline before 
being immediately frozen on dry-ice, and kept at -80oC until further analyses.   
 




 Eyestalk ganglia and Y-organs at various molt stages were homogenized 
in 100 µl ice-cold DEPC-treated PBS and dissolved in 0.1 M borate buffer (pH 
8.0).  The homogenized samples were assayed similarly as described [60].  The 
concentration of ecdysteroids was calculated using AssayZap program 
(BIOSOFT) and presented in pg/tissue.  Protein contents in eyestalk ganglia, Y-
organs, and hepatopancreas were estimated using a colorimetric assay, modified 
Lowry method (Pierce 660).   
 
3.2.5  MIH titers in hemolymph using RIA* 
A) Iodination 
 Native CasMIH was isolated and quantified as described (Chung and 
Webster, 2003).  300 pmol of CasMIH was iodinated by following the procedure 
as described [118,178].  125ICasMIH was separated on a PD-10 column (GE 
Healthcare) and diluted in glycerol (final 50%). Then it was stored at 4oC and 
used within one or two months after iodination.  The specific activity of 
125ICasMIH ranged from 300 to 500Ci/mmol.  
 
 
* MIH-RIA was performed and analyzed by Dr.Sook Chung 
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B) Hemolymph sample preparation 
 Hemolymphs were sampled from the animals at various molt stages.  
Hemolymph was directly withdrawn into a marine anticoagulant [186] at a ratio of 
1:1 (v/v) via the arthrodial membrane between a chela and the first walking leg.  
These samples were extracted in isopropanol (final 60%) and centrifuged as 
described [150].  The supernatants were recovered in Minisorb tubes (Nunc), 
dried by vacuum centrifugation (Jouan), and assayed in duplicate.  Anti-CasMIH 
was used at a 1:20,000 final concentration as before [23].  Standards of CasMIH 
RIAs ranged from1.2 X10-12 and 2.5 X 10-11M with ED50 values of 5.7 ± 0.1 ×10
-
10M (N = 3) and the detection limit of 1.2 x 10-12M.  The RIA data were analyzed 
as above.  
 
3.2.6  Knockdown effects on CasMIH expression in eyestalk and molt 
interval using double-stranded RNA ( dsRNA) 
 
 
 CasMIH-, CasEcR1-, and CasRXR-dsRNAs were generated using 
TranscriptAid T7 High Yield Transcription kit (Fermentas) as described [187].  
Prior to the experiments, the hemolymph (100 µl) was withdrawn from the all 
experimental crabs (60-70 mm CW), mixed in a marine anticoagulant at a 1:1 
ratio [186] and kept at -20oC until further assayed for ecdysteroid levels.  The 
knock-down effect with dsRNAs was determined in two ways: 1) the effect within 
the molt cycle by injecting 5-10 times over 20 days and 2) the effect within and 
after the molt by injecting ~30 times over 60 days.  In both cases, animals 
received 15 µg CasMIH-dsRNA (in 100ul crustacean saline) or CasEcR1-
dsRNAs three times a week as described [187].  The controls received the same 
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volume of crustacean saline.  In order to monitor the delivery of dsRNAs into the 
animals, the crustacean saline was spiked with a 0.01% phenol red as described 
[187].  At the end of experiments, the animals were at intermolt stage [114] and 
hemolymph was collected.  They were then anesthetized by chilling on ice for 5-
10 min and the tissue samples were collected as stated above. 
 
3.2.7  Expression levels of ecdysone receptor (EcR) and molt-inhibiting 
hormone (MIH) using qRT-PCR assays 
 
 
 The eyestalk ganglia and Y-organs at different molt stages, the eyestalk 
ganglia from incubation and dsRNA injection experiments were initially 
homogenized in 150 µl of ice-cold DEPC-treated PBS.  Total RNA extraction and 
cDNA synthesis were carried out as described above.  The cDNA samples were 
diluted to the final concentration at 12.5 ng total RNA/µl equivalent.  The eyestalk 
cDNA samples (25 ng of total RNA equivalent) were assayed in duplicate to 
estimate the levels of CasMIH and CasEcR1 using Fast SYBR Green Master Mix 
(Applied Biosystems) and qRT-PCR primers (listed in Table 3-1) on an Applied 
Biosystems 7500 instrument.  The expression of arginine kinase (AK) was 
determined in the same sample cDNAs as a reference gene for endpoint PCR 
and qRT-PCR assays.  The standards of all transcripts analyzed were generated 








Table 3-1.   List of primers that were used for qPCR assays and an end-point RT-PCR 
assay  
 
Primers Sequences (5'-3') 
CasEcR 
qF-short (EcR1/EcR2) CCAACAAGTCCAATGTCAGCCGGGG 
qF-long (EcR1a/EcR2a) CACTCCTAGCATCGTTCAGACT 
qR1 (EcR1/EcR1a) GGCATCCGAGTCGTCATCACTTATT 










3.2.8  Statistical analysis  
 All results represent mean ± 1SE (n), in which n is the number of 
replicates.  SigmaPlot (version 12.3) was used to evaluate the statistical 
significance of the results.  The data were subjected to the normality test using 
the Shapiro-Wilk test (SigmaPlot) prior to all statistical tests.  The data that did 
not show a normal distribution were analyzed using nonparametric ANOVA 
(Mann-Whitney Rank Sum test).  In all cases, statistical significance was 




3.3.  Results 
3.3.1  Levels of molt-inhibiting hormone ( CasMIH) expression in eyestalk 
ganglia and of CasMIH in hemolymph during the molt cycle 
 
 Levels of CasMIH expression during the molt cycle slightly increase (Fig. 
3-1).  At intermolt (C4), CasMIH expression levels are measured at 2.4 ± 0.2 x 
106 copies/µg total RNA (n=8).  These levels are increased to 6.0 ± 1.5 x106 
copies/µg total RNA (n=8) at D0 stage (P=0.09).  The CasMIH expression 
reaches 7.1 ± 1.4 x106 copies/µg total RNA (n=22) at D1/D2 stage and declines to 
6.1 ± 1.2 x106 copies/µg total RNA (n=7) at D3-4 stages.   
 
      
 
 
Figure 3-1 .  Expression levels of CasMIH in eyestalk ganglia during juvenile molt by 
qRT-PCR assay.  Each cDNA sample containing 25 ng total RNA equivalent was 
assayed in duplicate.  The expression levels are represented as copies/µg total RNA.  
The data are presented as mean ± SE (n).  Statistical significance was accepted at P < 






 The amounts of CasMIH stored in the sinus gland during the molt cycle 
are presented in Fig. 3-2.  At the intermolt and early premolt (D0) stages, CasMIH 
levels are similar and range from 53.9 ± 5.0 to 38.4 ± 8.3 pmol/sinus gland 
(n=10-12), respectively.  At the mid-premolt stage (D1/D2), CasMIH levels 
increase significantly to 121.5 ± 13.6 pmol/sinus gland (n=21) and at the late 
premolt (D3/4) stage, remain high at 105.3 ± 18.5 pmol/sinus gland (n=7), 
compared to those at preceding molt stages.  
 
 
Figure 3-2.   Storage levels of CasMIH in sinus gland (SG) by direct ELISA assay 
developed from Drexler [44,188].   
 
The concentrations of CasMIH in hemolymphs also change during the 
molt cycle.  CasMIH titers are similar ranging from 14.1 to 15.2 pM at intermolt 
(n=8) and mid-premolt D2 stages (n=14).  At early ecdysis (E0-5%), the CasMIH 








measured at intermolt and mid-premolt stages.  At post molt (B) stage, the levels 




Figure 3-3 .  Circulating levels in hemolymph of CasMIH during juvenile molt by RIA 
assays.  The data are presented as mean ± SE (n).  Statistical significance was 
accepted at P < 0.05 and noted with letters. 
 
3.3.2  Endogenous changes in ecdysteroid concentrat ions in eyestalk 
ganglia and Y-organs at different molt stage 
  
The ecdysteroid contents in eyestalk ganglia and Y-organs vary 
depending on molt stage (Fig. 3-4).  Both tissues have similar levels of 
ecdysteroids at intermolt stage: 2.3 ± 1.0 pg/µg eyestalk ganglia proteins (n=4) 
and 9.8 ± 3.4 pg/µg Y-organ proteins (n=6).  Ecdysteroid levels increase 
significantly (P =0.05) by four folds to 9.8 ± 3.5 pg/µg eyestalk ganglia proteins 
(n=6) at early and mid-premolt (D0/D1) stages, compared to those estimated at 
intermolt.  However, the ecdysteroid levels in Y-organs are increased only to 17.1 






values do not differ significantly.  The hepatopancreas, as a reference tissue has 
similar levels of ecdysteroids at intermolt: 38.1 ± 5.7 pg/ µg hepatopancreas 
proteins (n=5) and early and mid-premolt (D0/D1) stages: 36.6 ± 4.3 pg/ µg 
hepatopancreas proteins (n=7).  
 
 
Figure 3-4 .  Levels of ecdysteroid presence in the tissues assayed by Ecd-RIA.   
Eyestalk and Y-organ from intermolt (white bar, n=4-6) and premolt (black bar, n=6) 
stages of juvenile C. sapidus.  Protein estimation was performed by colorimetric assay 
modified Lowry method (Pierce 660). Statistical significance was accepted at P < 0.05 
and noted with asterisk.    
 
3.3.3  Effects of ecdysteroids on CasMIH expression 
Effects of ecdysteroids on the levels of CasMIH expression in the eyestalk 
ganglia obtained from the animals at intermolt stage differ by the concentrations 
of PoA:20-HE at a 3:1 ratio that mimic the concentrations at various molt stages 
(D0, D1, and D2) (Fig. 3-5).  At 75 ng/ml concentration (D0), levels of CasMIH 
expression are significantly up-regulated to 5.0 ± 1.2 x106 copies/µg total RNA 
(n=7), compared to those of the control (1.7 ± 0.6 x106 copies/µg total RNA, n= 






CasMIH expression tend to decrease to 3.9 ± 1.3 x106 copies/µg total RNA (n= 
16) and 0.3 ± 0.1 x106 copies/µg total RNA (n= 5), respectively.  However, these 
reduced CasMIH levels do not differ with the controls.  Levels of AK expression 
measured in the same sample cDNAs remain constant, ranging from 5.1 ± 0.6 
x106 copies/µg total RNA (n= 6) with the controls; 4.5 ± 0.5 x106 copies/µg total 
RNA (n= 8) at 75 ng/ml; 3.9 ± 0.6 x106 copies/µg total RNA (n= 8) at 150 ng/ml; 
and 5.7 ± 1.7 x106 copies/µg total RNA (n= 8).  
 
 
Figure 3-5 .  Expression levels of CasMIH in eyestalk ganglia after incubation with 
different concentrations of active ecdysteroids by qRT-PCR assay.  CasMIH expression 
in different ecdysteroid concentrations that are composed of 3:1 ratio of PoA: 20-HE.   
The ecdysteroid concentrations of 75, 150, and 250 ng/ml mimic the Do, D1, and D2 
stages, respectively.  C. sapidus Arginine kinase (CasAK) expression (Gray dot) was 
quantified from the same cDNA samples.  Each cDNA sample containing 25 ng total 
RNA equivalent was assayed in duplicate.  The expression levels are represented as 













3.3.4  Temporal-spatial distributions of ecdysone r eceptor ( CasEcR) 
isoforms in eyestalk ganglia and Y-organs during th e molt cycle 
 
 Four forms of CasEcRs are differentially expressed in eyestalk ganglia 
and Y-organs as well as at different molt stages.  Overall, the expression of 
CasEcRs is higher in Y-organs than in the eyestalk ganglia, while the AK 
expression in these tissues is constant (Figs. 3-6A and B).  In the eyestalk 
ganglia, CasEcR1 serves as the major form, while both CasEcR1 and CasEcR2 
seem to be equally distributed in the Y-organs (Figs. 3-6A and B, respectively).   
 During the molt cycle, the patterns of CasEcRs expression are also 
different in eyestalk ganglia and Y-organs.  In eyestalk ganglia, the CasEcR1 and 
CasEcR2 tend to be gradually increased at premolt stages (D0-D3-4).  However, 
both CasEcR1 and CasEcR2 in the Y-organs seem to be constitutively 
expressed throughout the molt cycle.  CasEcR1a in Y-organs shows a molt-stage 
dependent expression with greater expression at D1 and D2 stages than at the 
other stages.  
 
 
Figure 3-6 .  Spatial and temporal distributions of four CasEcR forms in eyestalk ganglia 
(A) and Y-organs (B) during the juvenile molt by end-point PCR assay (n=3).  CasAK 
serves as the loading control and obtained from the same cDNA samples.  Isoform 









3.3.5  Levels of ecdysone receptor ( CasEcR) expression in eyestalk ganglia 
during the molt cycle 
 
 The expression pattern of CasEcR1, which is the major form in eyestalk 
ganglia, is similar with Fig. 3-6.  Levels of CasEcR1 at the intermolt and mid-
premolt (D1) stages remain constant and range from 2.2 - 2.7 x10
4 copies/µg 
total RNA (n=6-7).  These levels are elevated to 7.0 ± 2.4 x104 copies/µg total 
RNA (n=8) at mid-premolt (D2) stage and continue to significantly increase (P 
<0.01) to 1.2 ± 0.2 x105 copies/µg total RNA (n=7) at the late premolt (D3-4) 




Figure 3-7 .  Expression levels of CasEcR1 in eyestalk ganglia during juvenile molt by 
qRT-PCR assay using isoform specific primers (Table 3-1).  Each cDNA sample 
containing 25 ng total RNA equivalent was assayed in duplicate.  The expression levels 
are represented as copies/µg total RNA.  The data are presented as mean ± SE (n).  
Statistical significance was accepted at P < 0.05 and noted with letters. 
 
   
 








3.3.6  Effects of CasMIH- and CasEcR1-dsRNA on CasMIH expression in the 
eyestalk ganglia and the molt interval  
 
 
 A preliminary time-course study with multiple injections of CasMIH-dsRNA 
significantly reduced levels of CasMIH expression (Suppl. Fig. S3-1).  CasMIH-
dsRNA injections reduce CasMIH expression by ~50-time: 8.0 ± 3.0 x104 
copies/µg total RNA (n= 9), compared to those that received saline (4.0 ± 1.3 
x105 copies/µg total RNA, n= 6) and CasRXR-dsRNA (3.4 ± 1.0 x105 copies/µg 
total RNA, n= 5).  Interestingly, CasEcR1-dsRNA significantly reduces the 
CasMIH levels (1.2 ± 0.4 x105 copies/µg total RNA (n= 9), compared to the 
controls.  However, CasRXR-dsRNA injections have no effect on the levels of 
CasMIH expression (Fig. 3-8).   
  






Figure 3-8 .  Expression levels of CasMIH in eyestalk ganglia after being administered 
with dsRNAs by qRT-PCR assay.  Each cDNA sample containing 25 ng total RNA 
equivalent was assayed in duplicate.  The expression levels are represented as 
copies/µg total RNA.  The data are presented as mean ± SE (n).  Statistical significance 
was accepted at P < 0.05 and noted with letters. 
 
 
 The molt interval of these experimental groups is shown in Fig. 3-9.  The 
animals injected with CasMIH-dsRNA have the molt interval with 14.5 ± 3.0 days 
(n=4) shorter (P= 0.0737) than the other groups including the control with 20.0 ± 
3.2 days (n=4), CasEcR1-dsRNA with 20.8 ± 1.2 days (n=5), and CasRXR-
dsRNA with 23.0 ± 3.0 days (n=5).   
 









Figure 3-9.   Molt interval after administered with dsRNAs.  The data are presented as 
mean ± SE (n).  All data were subjected to a normality test using the Shapiro-Wilk test 
(SigmaPlot).  When the data did not show the normal distribution, a nonparametric test 
(Mann-Whitney Rank Sum test) was employed.  Statistical significance was accepted at 
P < 0.05. 
 




3.4  Discussion 
 
Endocrine systems usually involve feedback mechanisms to maintain 
physiological homeostasis.  The present study describes the interplays between 
the levels of ecdysteroids and MIH in the blue crab, C. sapidus.  Our results 
demonstrate that eyestalk ganglia and Y-organs, although containing all four 
CasEcR expression, elevate the expression of a tissue-dependent major form 
during the molt cycle.  Effect of ecdysteroids on the levels of CasMIH expression 
in the eyestalk ganglia has been investigated by in vitro incubation studies with 
different concentrations and ratios of ecdysteroids.  In addition, the effects of 
ecdysteroids acting through EcR were examined by in vivo RNAi studies. 
Molting is one of the most fundamental physiological processes in the 
animals belonging to the phylum Arthropoda and recapitulates throughout their 
life cycle.  Crustacean molting and the molt cycle are coordinated and controlled 
by the levels of hormones produced by two endocrine systems: eyestalk ganglia 
and Y-organs.  It has been suggested in a simple way that animals at the 
intermolt stage carry low levels of ecdysteroids due to high levels of MIH that 
suppresses the activity of Y-organs.  The suppression of MIH on Y-organs is 
noted in a reduction of protein synthesis and cholesterol uptake in these organs, 
resulting in the reduction of ecdysteroid synthesis and secretion [39,181].  The 
MIH binding affinity to the Y-organ membranes prepared from different molt 
stage as well as the levels of its second messenger, cGMP do not change 
significantly [178].  On the other hand, the maximal number of binding sites 
increase significantly at post molt (B) stage [178].  These data indicate that the 
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inhibitory effects of MIH on the Y-organ may not result from the binding capacity 
or affinity of receptors.  Interestingly, it is reported at the premolt stage that the 
phosphodiesterase (PDE) in Y-organs increase and affect the levels of cAMP 
and cGMP in P. clarkii, thus alleviating the MIH/CHH actions [20].  However, the 
exact mechanism by which MIH regulates Y-organ activity through the molt cycle, 
remain still unknown.   
The levels of CasMIH expression in the eyestalk ganglia vary and 
increase at early premolt stage.  This result is rather different from those reported 
in C. maenas in which the expression levels remain constant [178].  In addition, 
the levels of CasMIH in the hemolymph and sinus gland appear to be higher at 
premolt than those of C. maenas [48] and CHH in C. sapidus [153].  Our results 
indicate that the transcription of CasMIH may be under the regulation of 
ecdysteroids as the upstream promoter region of CasMIH gene may contain EcR 
binding site.  Indeed, it is noted that the sequence of genomic amplification of 
CasMIH upstream promotor region (GenBank accession no KJ813010, Suppl 
Fig. S3-2) includes the binding site of RXR, and broad complex , similar as 
reported in C. pagurus [45] and Charybdis feriatus [47].   
If CasMIH expression is under the control of ecdysteroids, the eyestalk 
ganglia should respond to ecdysteroids in the hemolymph and show the increase 
in its binding capacity to ecdysteroids at premolt stage, compared to the 
intermolt.  To answer this question, the ecdysteroid contents in the eyestalk 
ganglia and Y-organs that were obtained from the animals at different molt 
stages were measured.  The results show that there are different levels of 
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ecdysteroid concentrations between these tissues.  The Y-organs contain higher 
concentrations of ecdysteroids than the eyestalk ganglia at both molt stages.  
However, the eyestalk ganglia at premolt seem to be able to concentrate or 
accumulate ecdysteroids by increasing four folds, whereas Y-organs show only 
~1.7-fold increase.  This indicates that the eyestalk ganglia are more sensitive to 
the hemolymphatic ecdysteroids than the Y-organs and may elevate their binding 
capacity to ecdysteroids.  The exact type of ecdysteroids in the tissues has not 
been characterized.  However, we infer that PoA and/or 20-HE may be the ones 
present in these tissues.   
Levels of hemolymphatic ecdysteroids change during the molt cycle, along 
with increase in the total concentrations as well as a particular active ecdysteroid 
[60].  The intrinsic concentrations of ecdysteroids mimicking the levels of early 
premolt stage with PoA:20-HE at a 3:1 ratio increase CasMIH expression in the 
eyestalk ganglia that were obtained from the animals at intermolt stage.  Our 
results are pertinent to an earlier finding in C. antennarius that ecdysteroids 
stimulate neuropeptide hormone production [28].  Interestingly, ecdysteroid 
concentration similar to that of early premolt stage is able to stimulate the 
CasMIH expression, but not with the highest concentrations (250ng/ml).  This 
implicates that there may be difference in a molt-dependent binding capacity of 
the eyestalk ganglia to ecdysteroids. 
At premolt, the increase in the total concentration of ecdysteroids is due to 
the elevated levels of PoA, yielding the ratio at 3:1 between PoA and 20-HE.  
Such changes in total levels and PoA may indicate the relative changes in 
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EcR/RXR expression.  The signal transduction of ecdysteroids requires a 
heterodimer complex of EcR and its binding partner RXR.  Interestingly, our 
results show that the distribution of CasEcR isoforms differs by tissues and molt 
stages.   In eyestalk ganglia, CasEcR1 expression contributes around 70% 
towards total CasEcR expression.  Structural property of the putative ligand 
binding pocket of CasEcR1 seems to be less hydrophobic than that of CasEcR2; 
therefore, CasEcR1 may prefer to bind to 20-HE rather than PoA.  However, 
levels of CasMIH expression in the eyestalk ganglia incubated with of a 1:3 ratio 
of PoA to 20-HE do not differ from the controls (Suppl. Fig. S3-3).  On the other 
hand, incubation of these two active ecdysteroids at a 3:1 ratio shows that only 
the ecdysteroids that mimicked intrinsic condition of early premolt (75 ng/ml) 
significantly and specifically increase the levels of CasMIH expression, while it 
has no effect on the levels of CasAK expression.  Thus, it appears that the initial 
elevation of ecdysteroids, particularly PoA, may be important, specifically in 
regulation of CasMIH expression.   
As our aim was to examine the initial stimulatory effect of ecdysteroids on 
CasMIH expression, we carried out 3 hr incubation studies.  Levels of CasEcR  in 
the eyestalk ganglia do not change compared to those measured in the control 
group.  EcR is in general known to be early-ecdysteroid responsive gene.  
However, there may be a critical and limited window of its expression after the 
exposure to ecdysteroids.  Indeed, up-regulation of EcR expression in limb buds 
of U. pugilator occurs only at 1.5 hr incubation with 20-HE but not at 2 or 2.5 hr 
incubation [189].  Thus, it is implied that up-regulation of CasEcR might have 
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taken placed earlier, which was then subsequently translated for transducing the 
signal and trans-activating CasMIH expression as shown in Fig. 3-5.  However, 
further studies are required particularly for establishing a relationship between 
the levels of transcription and translation of EcR in crustaceans using a time-
course incubation study.   
RNAi technique, specifically dsRNA, has been successfully employed in 
decapod crustaceans for functional study of a gene of interest [187,190].  Prior to 
carrying out the current experiment, injections of 5 and 10 µg CasMIH-dsRNA 
were tested in order to find an optimal dose that yielded the maximal reduction of 
the target gene expression.  Our preliminary data obtained from three injections 
at a two-day interval of 10 µg CasMIH-dsRNA showed ~ 90% reduction in 
CasMIH expression.  Our study with 30-time injections to the animals normally 
exhibiting molt interval (~20 days) shows that molting is slightly induced after 
CasMIH-dsRNA injections, having the shorter molt interval (14. 5 ± 0.6 days, P = 
0.0727), compared to other groups.  Our finding is pertinent to an earlier finding 
in the much smaller sized crayfish, C. quadricarinatus where multiple injections of 
CqMIH-dsRNA induce molting [190].   
CHH neuropeptides specifically produced in crustacean eyestalk ganglia 
tend to accumulate in the sinus gland, as similar to adipokinetic hormone in 
corpora cardiaca in insects [191].  The progress of life cycle accentuates their 
accumulation, suggesting that the amounts of MIH/CHH translation are far 
greater than what is actually required by the animal.  Although CasMIH levels are 
reduced >90% by multiple injections of CasMIH-dsRNA, it does not yield 
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dramatic molt inductions.  Perhaps the prolonged reduction of CasMIH levels 
over 60 days may induce the release of CasMIH stored in the sinus gland, 
although the newly translated materials in the neurosecretory neuronal cells are 
preferentially released first from the neurosecretory terminals in crustaceans and 
mammals [192-194].   
Interestingly, a long-term administration of CasMIH-dsRNA seems to be 
lethal as half of the animals died during the mid-premolt (D1 and D2) stage.  This 
might have occurred as off-target effects of CasMIH-dsRNA [195-197].  However, 
it is suggested that the lack of CasMIH may impair the Y-organ activity in terms 
of the ecdysteroid levels as well as the specific type of an active ecdysteroid.  
The eyestalk ablated C. sapidus at premolt stage carry 20-HE as the major 
ecdysteroid in their hemolymph, in contrast to the intact animals that use PoA as 
the major form [60].  Although it is not clarified in this current study, it will be 
intriguing to examine in the future, if indeed multiple injections of CasMIH-dsRNA 
may replicate a similar effect of the eyestalk ablation.   
We have also observed that CasCHH-dsRNA administrations produced a 
high mortality of the animals, particularly those that were undergoing the ecdysis 
process.  These animals were unable to shed the old exoskeleton.  As a result, 
they were usually trapped in the old skeleton.  Crustacean ecdysis relies on the 
hormonal regulation of a large uptake of iso-osmotic water [118].  The expression 
and release of gut CHH from the endocrine cells present in the fore- and hindgut 
are required for the completion of successful ecdysis [118,198].  It has been 
often observed in C. maenas that untimely discharged CHH from these 
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endocrine cells causes the death of animals during the ecdysis, exhibiting by the 
typical symptom of swelling of the body trapped in the old exoskeleton.  What we 
have observed is similar to what was reported in C. maenas [118].  And, we 
consider that CasCHH-dsRNA may affect the expression of the gut CHH 
expression, possibly its release, which results in a high mortality of these animals 
during ecdysis.   
The same amounts of multiple injections of CasEcR1- dsRNA indeed 
reduce CasMIH expression, strongly suggest that transcription of CasMIH  may 
be under the control of ecdysteroids.  However, CasEcR1-dsRNA injections 
seem to be less effective in knock-down of CasEcR1 expression and produce 
much less reduction, compared to those determined with CasMIH-dsRNA 
injections.  The levels of knock-down of a target gene by RNAi vary, depending 
on the levels of its expression as well as the function or property of that particular 
gene product [199-201].  We suggest, however, that this result may be due to the 
low translation rate of CasEcR or a slow turnover of CasEcR in the eyestalk 
ganglia.   
Indeed, translation of crustacean EcR including CasEcR appears to be 
tightly regulated.  The 5´untranslated region (5´UTR) of CasEcR cDNA contains 
upstream open reading frame as well as internal-ribosome entry site [119].  This 
indicates that translation of the CasEcR mRNAs may require a particular 
physiological condition(s).  Reduction of CasMIH expression upon CasEcR1-
dsRNA injection supports the fact that levels of CasMIH expression respond to 
the presence of ecdysteroids.  30-time injections of CasEcR1-dsRNA, but not of 
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CasRXR-dsRNA reduce by 70% of CasMIH expression.  EcR binds to 
ecdysteroids, while its partner, RXR, facilitates the liganded EcR to bind to the 
ecdysteroid-responsive elements.  As alluded to earlier, the upstream promoter 
regions of MIH genes of C. pagurus [45], C. feriatus [47], and C. sapidus 
(GenBank accession no. KJ813010, Suppl. Fig. S3-2) contain the binding sites 
for ecdysteroid-responsive factors.  Hence, it is suggested that reduced levels 
(~67%) of CasEcR might have generated the downstream effect on decreased 
levels (three folds) of CasMIH expression.   
With the data obtained from this study including the direct effects of 
ecdysteroids on the CasMIH expression, together with the previous findings 
[14,28,39,45], a regulatory mechanism for molt control in crustaceans is 





Figure 3-10.   Proposed model of molting control in crustaceans.  (1) Neuropeptides 
(MIH and CHH) secreted from the eyestalk ganglia suppress the ecdysteroidogenesis in 
Y-organs.  Autocrine feedbacks of ecdysteroids on the Y-organs may be generated from 
different ecdysteroid levels: (2) ecdysteroid concentrations at early premolt stage 
generate positive feedback while the levels at the premolt stages (3) inhibit the 
ecdysteroidogenesis in the Y-organs.  This study provides supporting evidence that 
premolt ecdysteroids have a stimulatory effect on eyestalk ganglia for neuropeptide 
production, particularly at transcriptional level (4), generating the long-loop feedback on 
Y-organs.  Based on the endogenous changes of CasMIH expression and storage in this 
study, it suggests that ecdysteroids might have positive effect on translational and 
storage processes (5).  On the contrary, ecdysteroids might suppress the secretion of 
neuropeptides as reported in Cancer antennarius [28](6).  Overall, this define model of 
molting control suggests that the interactions of ecdysteroids and neuropeptides 









At the early premolt, elevated levels of ecdysteroids may stimulate the 
MIH expression in eyestalk ganglia which is confirmed by an in vitro incubation of 
ecdysteroids as well as CasEcR1-dsRNA injections.  The exact cue for MIH 
release has not yet been identified in crustaceans.  However, the levels of 
hemolymphatic ecdysteroids may negatively affect the release of MIH.  The low 
levels of CasMIH at D2 stage are measured at the peak concentrations of 
hemolymphatic ecdysteroids, as an earlier report in C. antennarius [39].  The 
highest levels of CasMIH in the hemolymph are found at post-molt stage during 
which animals have the lowest levels of hemolymphatic ecdysteroids (Fig. 3-3).  
Such high levels of CasMIH preceding intermolt stage inhibit the synthesis and 
release ecdysteroids by the Y-organs, which may result in re-setting the molt 
cycle.  
This overall proposed model for molt control describes the two feedback 
mechanisms involving MIH in the eyestalk ganglia and ecdysteroids produced by 
Y-organs.  Firstly, the long-loop feedback includes the neuroendocrine axis 
between the eyestalk ganglia and Y-organs in that MIH inhibits the activity of the 
Y-organs at intermolt and post molt stage.  At premolt stage, elevated levels of 
ecdysteroids stimulate the synthesis of the MIH and may suppress its release, 
while ecdysteroids and their signaling pathway through EcR may have the short-
loop feedback for stimulating and inhibiting the ecdysteroidogenesis.  However, 
further studies for examining these following topics are required: 1) the levels of 
CasMIH synthesis in X-organs at different molt stages in response to the varying 
concentrations of ecdysteroids; 2) the binding affinity of a specific EcR on each 
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active ecdysteroid type; and, 3) consequent effects on MIH expression in the 











Figures S3-1 .  Expression levels of CasMIH from a time course study of CasMIH- 
dsRNA injections in eyestalk ganglia by qRT-PCR assay.  Each cDNA sample 
containing 25 ng total RNA equivalent was assayed in duplicate.  The expression levels 
are represented as copies/µg total RNA.  The data are presented as mean ± SE (n).  





Figure S3-2 .  Genomic arrangement of 
sapidus using GenomeWalker (Clontech).  The upstream promoter region was extended 
2,509 nt from the start codon.   The binding site for RXR (RXRE) is predicted on the 
region between -2,131 to 
found at the proximal region and clustered in tandem repeats using web
prediction of regulatory elements
MIH gene (Accession no. KJ813010) in 
-2,107 nt, while the binding site for broad complex (BR
-










Figure S3-3 .  Expression levels of CasMIH in eyestalk ganglia after incubation with 
different ratios of active ecdysteroids by qRT-PCR assay.  Two different ratios of 
PoA:20-HE were determined: 3:1 ratio ( black bar) and 1:3 ratio (Gray bar).   Each cDNA 
sample containing 25 ng total RNA equivalent was assayed in duplicate.  The 
expression levels are represented as copies/µg total RNA.  Statistical significance was 










CHAPTER 4  
 
General conclusions and future studies 
 
 
 This study supported the hypothesis that ecdysteroids stimulate CasMIH 
expression as evidenced by the effect of ecdysteroids on neuropeptide 
production in eyestalk ganglia.  Ecdysteroid levels as well as expression levels of 
CasMIH and CasEcR were examined in two different molt cycles: embryonic and 
juvenile molts.  In addition, both in vitro and in vivo experiments were conducted 
to verify the functional roles of ecdysteroids and the ecdysteroid receptor. 
The endogenous changes in ecdysteroid levels as well as expressions of 
neuropeptides and ecdysteroid-responsive factors during embryogenesis and 
juvenile molt are similar.  These results suggest that embryogenesis includes a 
molting process that occurs inside the embryonic envelope prior to hatching.  
During ovarian development, levels of maternal mRNAs encoding for 
ecdysteroid-responsive factors (CasEcR, CasRXR, and CasBTBDP) are very 
high, but the levels abruptly decrease when embryonic development is initiated.  
This suggests that these maternal factors are immediately utilized and involved in 
the initiation of embryogenesis when the transcription machinery has not yet 
functioned.   
During embryogenesis, the changing of ecdysteroid levels was similar to 
that found in the juvenile molt.  This result indicates that the embryonic 
ecdysteroids are produced by the newly developed Y-organs.  Interestingly, 
expression levels of CasEcR and CasRXR peak before ecdysteroids.  This 
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lagged peak of ecdysteroids is also found in the Y-organs of juvenile molt when 
expression levels of all CasEcR forms are peaked at the D1 stage, while the 
ecdysteroid peak occurs at the D2 stage.  This pattern is reported as a common 
response for negative feedback of ecdysteroidogenesis in both insects and 
crustaceans.  Therefore, CasEcR and CasRXR may be involved in the regulation 
of ecdysteroidogenesis in Y-organs.  In addition, temporal changes of 
ecdysteroid-responsive factors during embryogenesis may be derived mainly 
from the expressions in embryonic Y-organs.  
There appears to be a relationship between CasMIH and CasCHH 
expressions and the changes of ecdysteroid levels during embryogenesis.  
Similarly, during the last juvenile molt cycle, CasMIH levels at premolt were 
higher than those at intermolt.  The similar patterns of temporal expressions 
obtained from two different molt cycles in different life stages indicate that in 
every molt cycle, the interactions between ecdysteroids and neuropeptides are 
repeated.  Since the embryonic molt is considered the first cycle of molting in the 
C. sapidus lifecycle, interactions between ecdysteroids and neuropeptide 
hormones are roughly determined from the timing of their expressions.  As the 
ecdysteroid system is initiated before neuropeptides during embryogenesis, it is 
implied that ecdysteroids may stimulate neuropeptide expressions.   
However, much is still unknown about the translation and storage activities 
of CasMIH in X-organs and sinus glands, respectively.  The present findings 
suggest that high levels of CasMIH expression and storage during the late 
premolt may be utilized in postmolt and the consecutive intermolt as the secreted 
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levels at the postmolt stage are higher than other stages.  However, all the 
activities of CasMIH in transcription, translation, and storage are not completed: 
the expression and storage levels were only examined during intermolt and 
premolt stages while the secreted levels were covered in one molt cycle.  In 
order to fully understand CasMIH activities during the molt cycle, further studies 
in the following topics are required: 1) how much CasMIH is expressed and 
stored during the ecdysis and postmolt stages compared to the intermolt and 
premolt stages; and 2) how much CasMIH is translated in the X-organ in one 
molt cycle.  
An analysis of the effects of ecdysteroids on CasMIH expression were 
assessed via in vitro incubation with active ecdysteroids composed of PoA and 
20-HE at concentrations and ratios that mimicked the premolt stages of C. 
sapidus.   Only the 3:1 ratio of PoA:20-HE at concentrations that simulate early 
premolt and mid premolt (Do and D1) stages induce CasMIH expression.  This 
result suggests that PoA has a stimulatory effect on CasMIH expression whereas 
20-HE may interfere with PoA.  It is implicated that PoA may be the key factor in 
regulation of CasMIH expression.  
This incubation experiment was performed based on the endogenous 
ratios of ecdysteroids during the mid premolt (D2) stage.  The endogenous ratio 
of PoA to 20-HE during intermolt, and early premolt (Do and D1) stages are still 
unknown.  Therefore, the intrinsic ratios of PoA:20-HE in these stages need to be 
evaluated.  Thru results in this area, further incubation studies might be 
attempted to define the effects of PoA and 20-HE on CasMIH expression. 
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In the eyestalk ganglia, CasEcR1 is the major form and has LBP that is 
more hydrophilic than that of CasEcR2.  Considered to be an ecdysteroid 
property, the hydrophilic LBP of CasEcR1 is predicted to bind with 20-HE in a 
manner stronger than PoA.  The decreased stimulatory effects of ecdysteroids on 
CasMIH expression in higher concentrations of ecdysteroids may result from the 
increasing amounts of 20-HE in the ecdysteroid mixture that interferes with PoA 
binding with CasEcR1.  This suggestion requires further study to demonstrate the 
binding affinity of CasEcR1 and/or CasEcR2 to PoA and 20-HE.    
Unlike the effects on eyestalk ganglia, it is still unknown which type of 
active ecdysteroids regulate the feedback on ecdysteroidogenesis in Y-organs.  
Due to the challenges inherent in distinguishing ecdysteroids in the incubating 
media and newly secreted ones, experiments that focus on the Y-organ 
incubation are necessary.  By obtaining these results, the regulation process of 
ecdysteroidogenesis in Y-organs would be better understood.   
Based on the knowledge that ecdysteroids transduce signals through 
CasEcR, a master transcription factor in the ecdysteroid system, transcription of 
the downstream-responsive genes will be affected by CasEcR depletion.  In vivo 
experiments demonstrated that knockdown of CasEcR1 lead to a reduction in 
CasMIH expression.  This indirect effect of reducing CasEcR1 on CasMIH 
expression indicates that CasEcR1 may be involved in CasMIH transcription.   
In eyestalk, the expression profile of CasEcR2 is also similar to that of 
CasEcR1, and this putative isoform is predicted to better bind with PoA than 
CasEcR1.  Therefore, it would be interesting to know whether CasEcR2 is 
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involved in CasMIH expression.  Since the expression levels of CasEcR2 are 
much lower than CasEcR1, it is difficult to measure thru a SYBR green qRT-PCR 
assay.  This suggests a need to find other methods that are able to detect very 
low transcript amounts.  Therefore, changes of CasEcR2 expression in 
incubation studies and knockdown experiments could be analyzed and 
considered in CasMIH expression. 
Moreover, translation of crustacean EcR including CasEcR appears to be 
tightly regulated as its 5´untranslated region (5´UTR) contains an upstream open 
reading frame as well as internal-ribosome entry site [119].  This indicates that 
translation of CasEcR mRNAs may require a particular physiological condition.  
Protein levels of CasEcR during the molting and experiment need to be 
considered.  
When the investigation focused on the genomic arrangement of MIH 
genes in crustaceans, it was discovered that an upstream promoter of MIH 
contained the binding site for RXR and broad complex (Suppl. Fig. S3-2).  Thus, 
there is great evidence to support the hypothesis that ecdysteroids are acting 
through their responsive factors (EcR, RXR, or BTBDP) to trans-activate the MIH 
expression.   
Trans-activation of ecdysteroids on MIH expression could be determined 
through binding experiments in which the ecdysteroid-responsive elements of the 
MIH gene are tested for their ability to bind with different ecdysteroid-responsive 
factors.  By performing these experiments, the following questions can be 
answered: 1) Which forms of EcR have effects on MIH expression at the 
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transcription level? and, 2) What are the pathways through which ecdysteroids 
trans-activate MIH expression.  Is it acting through an EcR-RXR complex or other 
ecdysteroid-responsive factors such as a broad complex or BTBDP? 
All together, this investigation provided lines of evidence that demonstrate 
the effects of ecdysteroids on eyestalk ganglia.  Through this expansion of 
knowledge, the regulation of molting in crustaceans can be re-defined (Fig. 3-10).   
Premolt ecdysteroids consisting of PoA:20-HE at a 3:1 ratio stimulates MIH 
expression in eyestalk ganglia.  This increase of MIH production during premolt 
stages leads to the accumulation of MIH in the sinus gland as herein reported.  
This storage hormone could be further utilized in later stages.  It seems possible 
that premolt ecdysteroids also have a positive effect on MIH at the translational 
and storage levels.  On the contrary, secretion of MIH into the hemolymph may 
be inhibited by ecdysteroids as reported previously in C. antennarius [28].  
Considering all possible responses in MIH together, large amounts of MIH would 
be stored in the sinus gland and then are utilized during postmolt and in the 
consecutive intermolt as this study has shown.  A high secretion of repository 
MIH into the hemolymph at postmolt will inhibit ecdysteroidogenesis in Y-organs, 
resulting in re-setting of the molt cycle.    
This model proposes that long-loop feedback of ecdysteroids generates 
negative feedback for ecdysteroidogenesis in the Y-organ through the 
neuroendocrine axis in which ecdysteroids at premolt stages stimulate the 
synthesis of neuropeptide hormones.  In addition, temporal expression of 
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CasEcR in the Y-organs suggests that ecdysteroids may have short-loop 
feedback that stimulates and inhibits ecdysteroidogenesis.   
In summary, the major findings of this research study were: 
• C. sapidus experiences one molt cycle during embryogenesis, and this 
molt is considered the first cycle in its lifecycle.  
• Maternal ecdysteroids as well as CasEcR, CasRXR, and CasBTBDP 
are deposited in oocytes during ovarian development.  The presence 
of these maternal factors indicates that ecdysteroids may be required 
for initiating embryogenesis.  
• In both embryonic and juvenile molts, the levels of ecdysteroids and 
the expression levels of neuropeptide hormones (CasMIH and 
CasCHH) were correlated.  Higher levels of CasMIH expression were 
observed when ecdysteroid titers increase.   
• In vitro incubation studies revealed that only the combinations of 
PoA:20-HE ratios that mimic premolt ecdysteroids stimulate CasMIH 
expression in eyestalk ganglia. 
• In vivo studies indicated that the stimulatory effect of ecdysteroids on 
CasMIH expression is acting through CasEcR. 
 
 This study still requires further research to detail the stimulatory effect of 
ecdysteroids on the neuropeptide axis.  The following lists present remaining 
questions that need to be answered.  
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• The endogenous ratios of PoA and 20-HE at other molt stages such as 
intermolt (C4) and premolt (D0 and D1) stages: different forms of 
hemolymphatic ecdysteroids from these stages could be isolated and 
assayed by HPLC-RIA as described [60].  By having this result, the 
response of eyestalk ganglia on these ecdysteroid conditions could be 
tested and compared with the recent finding.  
• The expression of CasMIH including transcription, translation, and storage 
at ecdysis and postmolt stages.  By obtaining these results, effects of 
ecdysteroids on CasMIH at different levels could be determined. 
• Effects of different ecdysteroid ratios and levels on the sinus gland in 
eyestalk ganglia for CasMIH secretion.  As proposed, the inhibitory effect 
of ecdysteroids on the CasMIH secretion could be determined.  This result 
would determine whether ecdysteroids have an effect on CasMIH at the 
secretion levels.   
• Expression of CasEcR at protein level in eyestalk ganglia and Y-organ 
during molting cycle and in experimental conditions.  Since the 5’UTR of 
CasEcR mRNA contains uORF and IRES, the translation of CasEcR 
seems to be tightly regulated and depends on specific conditions. 
• Localization of CasEcR isoform in eyestalk ganglia and Y-organ.  
Antibodies that recognize CasEcR1/CasEcR1a and CasEcR2/CasEcR2a 
are required to detect the localization of CasEcRs in different molt stages 
and in experimental conditions.  This result will provide evidence to 
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support the presence of specific isoforms that transduce ecdysteroids in 
different tissues and conditions.   
• Binding ability of different CasEcRs with 20-HE and PoA as the putative 
CasEcR1/CasEcR1a and CasEcR2/CasEcR2a are predicted to bind with 
20-HE and PoA, respectively.  By obtaining this knowledge, the induction 
of CasMIH expression in eyestalk ganglia will be determined in a CasEcR 
form where the PoA exerts its signal.  In addition, as CasEcR expression 
in Y-organ is molt-stage dependent, the binding result would also provide 
information about the possible ecdysteroid that regulates 
ecdysteroidogenesis in Y-organs.   
•  Binding of ecdysteroid-responsive factors (CasEcR, CasRXR, and 
CasBTBDP) on the upstream promoter of CasMIH.  Binding of these 
factors on regulatory elements can be detected by Pull-down assay or Gel 
Shift assay (EMSA).  This result will provide strong evidence supporting 
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